Small dynamic growth companies
Turnaround situations and cyclicals
2. Small Dynamic Growth Shares
3. Earnings, Growth Rates And The PEG Factor
5. Liquidity, Cash Flow And Borrowings
8. Momentum And Relative Strength
13. Asset Situations And Value Investing
HARRIMAN HOUSE LTD
3A Penns Road
Petersfield
Hampshire
GU32 2EW
GREAT BRITAIN
Tel: +44 (0)1730 233870
Fax: +44 (0)1730 233880
Email: enquiries@harriman-house.com
Website: www.harriman-house.com
First published in 1992, this edition published by Harriman House in 2008.
Reprinted in 2010.
Copyright © Harriman House Ltd
The right of Jim Slater to be identified as the author has been asserted
in accordance with the Copyright, Design and Patents Act 1988.
ISBN: 978-0-85719-092-5
British Library Cataloguing in Publication Data
A CIP catalogue record for this book can be obtained from the British Library.
All rights reserved; no part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior written permission of the Publisher. This book may not be lent, resold, hired out or otherwise disposed of by way of trade in any form of binding or cover other than that in which it is published without the prior written consent of the Publisher.
No responsibility for loss occasioned to any person or corporate body acting or refraining to act as a result of reading material in this book can be accepted by the Publisher, by the Author, or by the employer of the Author.
I would like to thank Jeremy Utton for the idea that I should write a book on investment. His suggestion coincided with my son, Mark, finding a dearth of British books on the subject.
I would also like to thank Jeremy and my friends Sir James Goldsmith, Ian Watson, Bryan Quinton, George Finlay, Ralph Baber and Peter Greaves for reading the proofs and making some very constructive and helpful suggestions for improving the text.
Thanks are also due to Dr. Marc Faber for allowing me to quote him so extensively on Emerging Markets. Also a special word of appreciation to Warren Buffett for writing and saying so many interesting things about investment and allowing me to use them in this book.
I am also grateful to Brian Marber for the interview on technical analysis, for his comments and for his amusing stories.
My two sons have also been most helpful: Christopher by drawing his two cartoons and the bull and the bear, and Mark for long days of diligent work on the proofs, for his time and effort on research and for his many ideas for uplifting the content.
I would not live to tell the tale unless I included Pam Hall, my long-suffering secretary, who has typed most chapters so many times that she knows some of them by heart.
One of my sons is interested in the stock market. After reading a number of quite advanced American books on investment, he asked me if I could recommend a British book of a similar nature. I searched my mind and then the bookshops, only to find that there was nothing beyond the primer stage. Market forces usually begin to fill a gap; hence my decision to write this book. I have no doubt that many others will follow.
My intention is to show you how to become a very successful investor. My problem is that I do not know if you are an aspiring trainee stockbroker; an accountant or a lawyer who has an understanding of many of the rudiments of investment; or someone who is in a very different line of business or who has retired after a lifetime in industry. I do not want to bore the people who understand the basics, so I shall assume that you are connected with the business of investment in some way or that you have read the Glossary at the end of this book. Either way, you will then know the difference between an ordinary share, a preference share and a convertible debenture; the meaning of terms like price earnings ratio, dividend yield and asset value; and the effect and significance of scrip and rights issues.
There are a number of different methods and areas of investment, some of which I will explain to you in much more detail in later chapters:
Fast-growing companies with market capitalisations ranging from £5m to £100m are not researched frequently by the investment community, so their shares are often exceptionally attractive.
Companies that have been hit hard by a recessionary environment or other exceptional factors are often due for a rebound. These situations involve cyclical companies and those which have recently had a change of management.
Shells are another exciting medium of investment. These are often very small companies that have a quotation, a small, nondescript business of little account and occasionally some cash. Usually, the idea of the incoming entrepreneur is to obtain a backdoor quotation for his company, which has too short a record, or some other shortcoming which precludes a more conventional route. There are many examples of successful and sometimes infamous shells from Hanson and Williams Holdings to Polly Peck and Parkfield. The ride can be very exciting.
Some of my friends invest solely in companies in which the shares have a market value less than the worth of the underlying businesses on a break-up. These value investors wait for a trigger, such as a bid or the arrival of new management, to revitalise the assets and bring them up to their full earnings potential. The shares then begin to appreciate in value.
Companies in the FT-SE 100 Index usually offer the comfort of size and rarely fail completely. These kinds of shares can also be sold much more easily even in bad markets. They are, however, well analysed by the investment community, increasing the difficulty of finding a real bargain. I intend to give you some selective criteria that should improve your investment performance with leading shares in this country. I have also found that my criteria work extremely well in America and most overseas markets.
If you need to read the Glossary please do so now, as I am anxious to show you how to make some money by using an approach that I have named ‘The Zulu Principle’. You will not be spending any time on gilts, preference shares, loan stocks and the Japanese market. Instead, you will concentrate upon five different ways of making money by investing in ordinary shares before you finally select one method or perhaps two that suit your temperament.
I first named this approach ‘The Zulu Principle’ after my wife read a four page article on Zulus in Reader’s Digest . From that moment onwards she knew more than me about Zulus. If she had then borrowed all the available books on the subject from the local library and read them carefully she would have known more about Zulus than most people in Surrey. If she had decided subsequently to visit South Africa, live for six months in a Zulu kraal and study all the available literature on Zulus at a South African University, she would have become one of the leading authorities in Great Britain and possibly the world. The key point is that the history of Zulus and their habits and customs today is a clearly defined and narrow area of knowledge into which my wife would have invested a disproportionate amount of her time and effort, with the result that she would have become an acknowledged expert. The study of this noble people might not have been profitable, but there are many other very specialised subjects that would have been very rewarding financially.
I now intend to show you how to use The Zulu Principle with your investments. You will achieve your objective, like Montgomery and Napoleon before him, by concentrating your attack.
The Zulu Principle explains how important it is to focus when investing. It is no good trying to be master of the universe. It is better to specialise in a narrow area and become relatively expert in it.
I have always focused on small and micro-cap stocks. The reasons are obvious – first, they are under-researched so better bargains are available and second, on average they perform very much better than larger-cap stocks. In fact over the last fifty years micro-cap stocks have outperformed the market by more than eight times.
In The Zulu Principle I outline the methods I was using for investing in 1992. Since then I have refined my approach a little but it is fundamentally the same.
First, I look for a tailwind. By this I mean concentrating on an area or sector which has a very favourable outlook. If you are in the wrong business at the wrong time you are bound to lose money. If you are in the right business at the right time it is very difficult not to make a lot of money.
One way of ensuring that you are in a business with a favourable outlook is to make sure that the relative strength of the sector and the stock you fancy in it is very positive in the previous year compared with the market as a whole. This is something I always check to make sure that the market does not know something horrible which is not yet public knowledge.
As part of my Zulu Principle focus I concentrate on growth shares. As I have explained, I much prefer companies with a small market capitalisation and to illustrate this I coined the expression ‘Elephants don’t gallop’. I also look for shares which are a relative bargain at the time of purchase. This is determined by comparing the prospective price-earnings ratio with the forecast growth rate. Ideally you want to ensure that the prospective price-earnings ratio is well below the growth rate. For example, a company on a multiple of 15 would be very attractive if its growth rate was 30% per annum and very unattractive if its growth rate was only 5% per annum.
It is no good simply looking at one year’s growth. It is vitally important that the company should have a reasonable record of growth. At the very least there should be two years’ past growth and two years’ forecast growth. Three years’ past growth and one year’s forecast growth would also be acceptable. Anything less than this would not give enough of a basis to determine that the growth is real growth as opposed to recovery from a setback.
Another very important criterion is to make sure that cash flow is in excess of earnings per share. Too many companies seem to be doing well until you analyse their accounts and find that their earnings per share are not backed by cash. They are phantom profits. By ensuring that cash flow is regularly in excess of earnings per share you can avoid the Enrons of this world.
Another vital criterion is to ensure that the directors are not selling their shares. Sales by more than one director would be enough to put me off completely, however impressive the statistics appeared to be. Conversely, it would be very bullish if several directors were buying. Particular note should be taken of buying by the chief executive and the financial director. They ought to know exactly what is happening within the business and it is always encouraging to see them putting their money where their mouth is.
About eight years ago, James O’Shaughnessy wrote a very interesting book, What Works on Wall Street , in which he analysed the performance of shares with different characteristics over a forty year period. He found that by following one sensible criterion such as strong cash flow or good relative strength in the previous year, you would have outperformed the market by a considerable margin. With this concept in mind, it is obviously far better to apply a combination of several sensible criteria for share selection and in The Zulu Principle that is exactly what I suggest you should do. Ideally I look for:
As we go to press the market outlook is very uncertain. The easiest money is to be made by shorting shares with excessive gearing and diminishing prospects. The multiples on growth shares are falling but this correction is necessary to provide the basis for future exceptional gains. So be of good heart and prepare yourself for the next upswing.
May the force be with you!
Jim Slater
September 2008
Investment is no different from any other game. Winning is much more fun than losing, and luck and skill both play their part. Bad players often complain about their luck, but as Gary Player, the famous golfer, said, ‘The harder you work, the luckier you get.’ Elmer Letterman put this another way, ‘Luck is when preparation meets opportunity.’ Let me show you how to prepare for investment and become a winner.
There is a great deal of luck in Monopoly. If you have bad dice, you might travel around the board paying huge amounts of tax and end up sitting in jail while your opponent snatches all the good sites. However, there is a small skill element in the game, and over a long period better players will win more often. Let us analyse the skill. The light blue properties – Pentonville Road, Euston Road and The Angel Islington – give the highest rental return of 159% compared with only 101% from the worst. The orange sites – Vine Street, Marlborough Street and Bow Street – are next best with a return of 141%. This yield is calculated by taking the total cost of buying all three orange sites and building hotels, which in this case is £2060, and comparing this figure with the rental on the three hotels, which would be a total of £2900. At first blush the light blue sites would seem to be better than the orange ones, but Vine Street, Marlborough Street and Bow Street are my favourites because of another important factor – the frequency with which your opponents are likely to land upon them. Firstly, there is a card in Chance ‘Go back three spaces’, and from one position this would put them on Vine Street. Secondly, the orange sites are a dice throw away from jail, which means that other players being released are more likely to land upon them. Thirdly, there are two other cards in Chance, one of which directs a player to ‘Take a trip to Marylebone Station’ and the other to ‘Advance to Pall Mall’. Following these directions bypasses the light blue sites completely and leaves your opponents poised to visit the orange sites.
A further Monopoly guideline is to build quickly once you have a complete site, even at the expense of mortgaging other incomplete sites to do so. For example, the loss of rent on the Strand would be only £18 but £100 out of the mortgage proceeds of £110 could be used to buy an extra house on Bow Street. The first house takes the rent from £14 to £70 to give a gain of £56, and the difference rises to as much as £350 when the third house is added. Subject therefore to keeping a prudent cash reserve, you should mortgage all incomplete sites and use the proceeds to build rapidly.
Before you participate in the game of investment, you should make sure that you acquire the necessary skill and that you can afford the stakes. I strongly recommend that you first invest in your own house or flat. In June 1992, property is in the doldrums, but for that reason it is a far better buy than a few years ago at the height of the property boom. As a long-term investment you can hardly do better, and there is a big bonus – you live in your house with enjoyment. Even with inflation at 5% per annum, a house costing £100,000 would tend to keep in line and, in a man’s normal lifespan, appreciate in value over the seventy years to more than £3,000,000. The arithmetic is even better than this though, because most people would have an affordable mortgage, so the return on their net outlay would be much enhanced. In addition, there is still no capital gains tax on owner-occupied houses, and there is some tax relief on mortgage interest. You cannot afford to invest in the stock market before taking advantage of these privileges.
You also need to ensure that you have some money set aside for school fees, illness and a rainy day. The money that you are going to use for investment in shares has to be patient money that will not need to be withdrawn suddenly.
In the investment game your main problem is that you will be up against full time professionals who eat, drink and sleep investment. They have readier access to the companies in which they are likely to invest, more general information at their disposal and they are regularly bombarded with brokers’ circulars and investment recommendations. In addition, brokers hoping for more business give the institutions their best possible service and keenest terms.
So you start off at a considerable disadvantage. There is a way to win, but unless you are prepared to dedicate a few hours a week to your investments, you will have no hope of succeeding. I suggest an average of at least half an hour a day – thirty minutes that I hope you will look forward to and enjoy.
To compete you need to develop an edge, so let me encourage you now with a few ideas. First you must find a market niche that is under-exploited by the professionals. Most leading brokers, professional investors and institutions concentrate their analytical skills on major companies with market capitalisations of £500m or more. The reasons for this are obvious. If a broker can produce a good argument for buying or selling a leading stock, institutions will be able to deal in volume, and a large turnover (with hefty commissions for the broker) will be the likely result. The institutions prefer leading stocks because their marketability is better. When they come to take a profit or cut a loss, they can usually deal in volume at a very keen price.
Investment is essentially the arbitrage of ignorance. The successful investor believes he knows something that other investors do not fully appreciate. There is very little that is unknown about leading stocks, so in that area of the market there is hardly any ignorance to arbitrage. GEC, Glaxo and ICI are the subject of hundreds of brokers’ circulars every year. In contrast, some smaller stocks are not written up at all and others by only one or two brokers. Most leading brokers cannot spare the time and money to research smaller stocks. You are therefore more likely to find a bargain (with some ignorance to arbitrage) in this relatively under-exploited area of the stock market. This is a possible niche for you.
The second factor that gives you an advantage over professionals is that they usually have to invest a massive amount of money. Many of them manage billions. Try to imagine some of the problems you would have looking after just a paltry £500m:
A further aid to overcoming expert competition is to apply The Zulu Principle to investment within your chosen niche market. I will show you five different approaches and suggest that you specialise in one of them. To begin with, we will look at a method of investing in relatively small companies that have shown strong past earnings growth, have future potential and appear to be rated inadequately by the market. I have profited most from investing in this kind of share and for that reason will deal with this system in considerable detail. The first ten chapters should help you to get the feel of the investment business before you progress to separate chapters on turnarounds, shells and asset situations. You should then be able to judge which approach will best suit your temperament. You need patience for asset situations and smaller growth stocks, in contrast to the more immediate pain or pleasure that will be felt by investing in shells and turnarounds. Investment in overseas markets and leading UK stocks are the subjects of separate chapters in which I set out some selective criteria for improving portfolio performance.
Let us now look at smaller growth stocks in more detail. You are searching for those that appear to be inadequately rated by the market. Sometimes there is a good reason for the market’s lack of enthusiasm. Your skill element will be finding out which companies deserve a much higher rating and which do not. Needless to say, you cannot expect to be right all of the time, but when you make a really good choice, your capital profit will surprise you and far outweigh the losses from occasional mistakes.
There are two basic reasons for growth shares increasing in price and providing you with substantial capital profits in the process. The first is the earnings growth itself. If a share is priced at ten times earnings and in the next set of results shows 25% earnings growth, all things being equal the shares will naturally appreciate by about 25%. The second reason for an uplift in price then comes into play. During the few months following the results, the market would be very likely to re-rate the shares to a more appropriate multiple, which for a company growing at 25% p.a. would be at least 20 and probably much higher. The status change in the multiple would increase your gain from 25% to 150%.
Another factor that contributes to the success of investment in smaller companies is that generally speaking elephants don’t gallop. The last year or so has been exceptional, and a few elephants have charged both here and in America, whereas smaller companies have lagged behind. The Hoare Govett Small Companies Index beat the FT AllShare Index in 27 of the last 37 years. Over the last ten years, the HGSC Index under-performed the market by 6%. 1989, 1990 and 1991 were all poor years for small companies, with three successive years of under-performance occurring for the first time. This reflects the increasing dominance of institutions in the UK market and their preference for leading stocks. There is also no doubt that in recessionary times smaller companies have a higher operational risk. Nevertheless, I believe that the potential rewards more than counterbalance this, making carefully selected, small to medium-sized companies an even better buy today.
Sainsbury, one of our most successful companies, is at the time of writing valued by the stock market at about £8bn. The management will find this vast capitalisation very hard to double during the next year or so. The rating is already high at 18 times historic earnings, and most institutions have their quota of Sainsbury shares. Smaller companies have more to gain from new investors discovering them, and as their following develops, so does the share price. For example, the shares of a little company like The MTL Instruments Group (which you will hear more about later) had no difficulty in doubling in twelve months. In February 1991, the shares were 124p, with the company on a multiple of 11 times earnings capitalising at £21.7m. One year later the shares were 275p. 1990 earnings were 20% up on the previous year, and 1991 earnings looked like increasing by a similar amount. The historic price earnings ratio was re-rated from 11 to 16, and hey presto by February 1992 the market capitalisation had increased from £21.7m to over £48m.
1. Make a conscious decision to devote at least three hours a week to your investments.
2. Read the whole of this book before selecting an approach to investment that you feel would be most suitable for your temperament.
3. When you have selected your niche market become as expert as possible in that particular area of investment. As Warren Buffett, the legendary American investor, says, it is not necessary for an investor to know more than one thing, but he certainly has to know that.
We will now move on to look in much greater detail at my system for investing in the dynamic growth of smaller companies.
In 1959, I was Commercial Director of AEC Limited, travelling extensively overseas. On a visit to Spain I contracted a viral illness, the after-effects of which lasted for several years. I began to worry that I might not be able to carry on with such a strenuous job for any length of time. I decided that there was only one answer – I had to build some capital and an alternative source of income.
It was no accident that I chose Stock Exchange investment. Shares could be a profitable hobby easily managed while I still retained my job. The only problem was how to become relatively expert in the chosen specialist subject.
At the time there were two weekly investment magazines, The Stock Exchange Gazette and the Investors Chronicle , now both merged under one title. I decided to apply the approach that I subsequently named ‘The Zulu Principle’. To begin with I purchased two years’ back copies of both magazines, and during a convalescent period in Bournemouth read through them page by page. I was convinced that the stock market winners of the past would have some common characteristics. If, with the benefit of hindsight, I could develop a formula based upon these characteristics, I was sure that I would be able to make my fortune.
I soon discovered that shares with a rising trend in earnings that also seemed to be on a relatively inexpensive multiple (earnings yield at the time) out-performed the rest of the market by a wide margin. A few failed to do so, and this made it essential to find out why and to devise some additional criteria that would help to erect a safety net under my selections.
During the following year I honed my system before putting it into practice – with astounding success. The market was in a bullish phase, which was obviously a helpful factor. As I began to succeed I gave investment advice to a number of friends, and also formed a small investment club for the executives of Leyland and AEC. I also gave investment advice to my boss, Donald Stokes, and a number of other colleagues. Like a child with a new toy, I wrote to Nigel Lawson, who was at the time the City Editor of the Sunday Telegraph . He thought my ideas had merit, and asked me to write a column each month under the pseudonym of ‘Capitalist’.
Nigel Lawson introduced the first article with these words:
‘Today we welcome a new contributor to the City Pages of the Sunday Telegraph – ‘Capitalist’. This is the pseudonym of a director of a number of well-known industrial companies in Britain and overseas who, in his spare time, has developed a highly successful new approach to investment. In this first article he explains his methods and selects the first three shares for his portfolio. In subsequent articles he will add further shares to the portfolio and review its progress to date.’
I explained in the article that I was looking for shares with an above-average earnings yield (the equivalent today would be a below average price earnings ratio) coupled with above average growth prospects, and I outlined nine important investment criteria. It is interesting to look back on them, and I quote directly from the article:
The system worked – the Capitalist portfolio appreciated in value by 68.9% against the market average of only 3.6% during the same two year period from 1963 to 1965.
Since then market conditions have changed, and I have had a further twenty-seven years’ investment experience. Needless to say I have modified, improved and added to my original criteria. Let me set them out for you as they are today, broadly in order of importance, together with a few explanatory notes which will be elaborated upon in later chapters:
This one is unchanged. The odd hiccup must be allowed for, but otherwise look for steady growth of at least 15% per annum. The word ‘steady’ eliminates cyclical stocks.
A shorter record can be acceptable if there has been a recent sharp acceleration in earnings growth which might be due to new factors, which would make the historic earnings less relevant.
Do not pay an excessive price for the future earnings you are buying. Look for a modest P/E ratio in relation to the earnings growth. There is an easy way of measuring the value you get for your money which is explained in the next chapter.
If the chairman is pessimistic, earnings growth could be at an end. Watch with bated breath for his statement and for the interim results.
Look for self-financing companies that generate cash. Avoid companies that are capital intensive and are always requiring more money for new machinery or even worse, for the replacement of old machinery at a vastly higher cost. Of course, capital expenditure is essential, but some companies simply eat cash, whereas others spit it out.
There are two ways of checking liquidity. The first is very simple – see if the company usually has a positive cash balance. Watch out for overdrafts and short-term loans on the other side of the balance sheet. You are looking for net cash. The second method is to determine the cash flow by analysing the accounts. You will learn how to do this. Meanwhile simply remember that you are trying to find companies that generate cash.
The ideal business is one you can rely upon to produce increased earnings per share year after year. This reliability is usually based on the competitive advantage of well-known brand names, patents, copyrights, market dominance or a strong position in a niche business.
Coca Cola and Guinness are examples of businesses with strong brand names and market dominance. MTL Instruments is an example of a leading company in the niche business of intrinsic safety, including anti-explosive devices. An oil company buying a safety device that would help to prevent its oil rig from blowing up would not quibble too much about the price. Photo-Me International and Rentokil are other examples of companies with strong names and distinct niches.
You are trying to identify businesses which are not operating in an over-crowded market where intense competition will erode margins. The key points are that the product or service the company is supplying should not be easy to substitute; and new entries into the industry should be hard to envisage. A quick way of obtaining an idea of a company’s relative strength in its industry is to examine pre-tax profit margins and the return on capital employed.
You want shares to have a story. Something new. Something that has happened relatively recently: a new factor in the industry like the failure of Harry Goodman’s International Leisure Group in the holiday business, with Owners Abroad and Airtours benefiting massively from the removal of major competition; a new palm-top computer from Psion that swept the board at an American computer show. A new Chief Executive from a very successful firm like Glaxo or Hanson is one of the most reliable new factors because the benefits will be far-reaching and on-going. Greg Hutchings from Hanson joining F.H.Tomkins is an obvious and very successful example. All of these new factors are potential reasons for a substantial increase in future earnings and form the basis of the story upon which the shares will be bought.
As elephants don’t gallop, you should give preference to companies with a small market capitalisation in the region of £10m-£50m, with an outside limit, in most cases, of £100m.
Sometimes shares perform poorly in the market in spite of very appealing fundamentals. Other investors may be selling after becoming aware of problems that you have not yet identified. Your broker should be able to let you have copies of Datastream charts (like the one below) showing the relative performance of your chosen shares against the market. If the shares are not keeping up with the market, you should be on red alert. At the time of purchase, as a quick rule-of-thumb cross-check, make sure that the growth shares you select are within 15% of their maximum prices during the previous two years.
The dividend yield can be well below my original 4%, provided that dividends paid are growing in line with earnings. Some institutions or funds will not invest in the shares of companies which do not pay dividends. We are anxious not to preclude any of them from participating in our selections.
Very few UK growth shares in a dynamic phase are priced near to or below book value. Although you should welcome the comfort of a strong asset position, remember that book values are often unreliable. A property value could easily be overstated, whereas an excellent brand name may be in the books for next to nothing.
You want the Directors to have a significant shareholding in relation to their personal finances – the actual amount of money involved is relatively unimportant. You are looking for shareholder-orientated management that will look after your interests with the ‘owner’s eye’. Avoid companies which still have two classes of shares, one of which gives extra votes to management. The ideal scenario is for management to have about 20% of the company so they are highly motivated but cannot block a bid.
There is no doubt that out of all of the above factors, the one that matters most is the relative cheapness of the P/E ratio in comparison with the growth rate. As you will see in later chapters many of the other criteria help to form a protective safety net around this fundamental requirement.
Before we progress any further let me whet your appetite with an example of a share that fulfilled my criteria in early 1991. As mentioned earlier, MTL Instruments is in the growing business of making safety devices for oil rigs, boiler rooms and chemical plants. Let us check off the statistics as they were in March 1991:
Earnings per share grew as follows:
*Available from the offer document
You can readily see that earnings were increasing at over 20% per annum.
At 150p the shares were priced at 11 times 1990 earnings and at 9.5 times the forecast for 1991. Earnings per share had grown at more than 20% compound since 1983, 21% in 1990, and the company was determined to grow at 12% in ‘real terms’ in 1991. With inflation running at 8.7% in March 1991 this could be interpreted as at least 20%.
In his statement the Chairman said that he was ‘confident that MTL will continue to make good progress.’ Brokers’ forecasts, new product developments and an expanding market also supported his view.
MTL enjoyed a superb financial position, with £4.7m net cash (equivalent to 18% of market capitalisation) and a strongly cash generative business.
With 60% of the UK market and 25% of the world market, MTL could safely be said to have a powerful position in the niche industry of manufacturing intrinsic safety devices.
There was nothing ‘new’ except the company’s innovative policy and a growing acceptance of the need for intrinsic safety. Given the company’s very strong showing on all the other criteria, this was not a cause for concern.
With the shares at 150p MTL was capitalised at £26.3m. Small enough to have been overlooked by institutions.
At 150p the shares were on their high.
Steadily rising dividends since one was first paid in 1988. The historic yield was an acceptable 2.5%.
Net assets per share stood at 52p, just over one third of the share price. Not very attractive in their own right, but passable for a growth share.
Directors, families and associates held 55.5% of the shares with a value of over £14.5m. Clearly the Directors could block a bid but they would certainly have the ‘owner’s eye’.
As you can see most of my criteria were well satisfied, the main exception being ‘something new’. One year later, in March 1992, the shares had risen from 150p to 295p, giving a capital gain of 97% compared with the dismal performance of the market average of less than 5% during the same period. Increased earnings made a contribution to the gain but the major factor was the status change in the multiple.
MTL was an easy choice as most of my criteria were so obviously satisfied. Frequently, your decision will be much more difficult as your selection may not measure up on every count. You will need to know the criteria upon which you can place the most reliance and those that are less important. To this end, we must move on now from the stark outline I have given you to a much more detailed understanding of each of the criteria.
The earnings of a company are the net profits after tax attributable to ordinary shareholders. If a company has earnings of 10p per share and a P/E ratio of 10, the shares would be priced at £1; with a P/E ratio of 20, the shares would be £2; and with a P/E ratio of 50 – £5. The annual rate of growth in earnings and the projected future rate of growth are the main factors which determine the multiple. The P/E ratio is the measure of how much you are paying for future growth and how much others have paid before you.
Earnings are the engine that drives the share price. If the engine fails or falters the shares will come down. The two charts overleaf show at a glance the close relationship between the earnings and the share prices of Glaxo and Hanson over the last fifteen years. There can be no doubt that earnings per share growth and the performance of share prices are umbilically linked, although there may be long periods during which they get out of kilter.
Very few companies can maintain a growth rate of over 30% per annum for more than a few years. The best bargains are usually found in the 15%-25% p.a. bracket. If you can identify a share growing at a sustainable rate of 20% p.a., it is almost beyond price. Even if you have to pay thirty times earnings, within five years earnings per share would have increased by 150%, and if the share price remained the same the P/E ratio would have fallen to 12. In fact, all other things being equal, the P/E ratio for such a share would still be in the high 20s, so you would have at least doubled your money. You should also bear in mind that P/E ratios are usually higher in a non-inflationary climate. In times of lower interest rates the attractions of a share with a compound growth rate of 20% per annum are obviously much more apparent and contrast very favourably indeed with most alternative uses of money.
Let us examine how earnings per share have grown for the FT Ordinary Share Index during the last ten years. The average compound growth rate in earnings per share is about 10% per annum, whereas the average P/E ratio is approximately 11.7.
Source: Datastream
The compounding effect of above average annual earnings growth is the vital factor that makes high-growth stocks so desirable. Here are a few typical growth rates within the range we are seeking:
Clearly, the ideal investment is a company in which earnings per share are growing annually at a high and sustainable rate. If this kind of share can be purchased on a price earnings ratio below the market average, you have discovered a jewel beyond price. If the price earnings ratio is above the average of the market but modest in relation to the growth rate, you have still found a rare gem. Remember that there are only two basic reasons for a growth share appreciating in price. The first is earnings growth and the second is the increase in the multiple that the stock market awards to the company. The status change in the multiple can often be far more important than the growth in earnings.
To avoid paying an absurd price, I suggest that you use this check list first for measuring the P/E ratio of any share you are considering buying:
Avoid stocks with astronomic ratings. Too many things can go wrong, and if anything does the fall will be catastrophic. Let me chill you with a look at some very high-multiple stock market favourites of yesteryear to see where they are today.
As you can see, all of the companies that were so highly rated still exist but their multiples have had a reverse status change, especially in the USA where prospects are so often over-discounted.
After you check your selections against my three standards, I recommend you to take a very important additional measure. The P/E ratio can often simply be compared with the prospective growth rate. A company growing at 15% per annum should certainly command a P/E of 15; at 20% per annum a P/E of 20 and so on. By dividing the growth rate into the P/E ratio a price earnings growth factor (PEG) is established, the aim being to find shares which have a PEG of well under one .
Let us look at a few leading examples. Rentokil has been growing at a compound rate of approximately 20% per annum, and therefore for a company of such quality a prospective P/E ratio of about 20 would be justified. Unilever, growing at an average of about 11% per annum, commands a lower multiple in the region of 11.5. Both would have a PEG of about one. Another share might be on a multiple of 30 with a growth rate of only 20% per annum. The PEG would then be significantly over one at 1.5, and the share would be obviously expensive. Conversely, another share growing at 20% per annum on a multiple of only 10 would have a very attractive PEG of 0.5. Our target is a prospective PEG of not more than 0.75 and preferably less than 0.66. Put more simply, we want the multiple of estimated future earnings for the year ahead to be not more than three-quarters of the growth rate and preferably less than two-thirds.
You will remember the example of MTL in the previous chapter. The prospective multiple in March 1991 was about nine times estimated earnings for the year ahead. With an estimated growth rate of 20% per annum the prospective PEG was a very attractive 0.45.
At the lower levels of growth like 12.5% to 17.5% per annum the PEG formula works very well. At higher levels of growth you can stretch the P/E ratio a little. The reason for this is the compounding effect of earnings growing at an exceptional rate.
Let us look at three examples, small companies A, B and C, assuming that their share prices started at 100p and rose in line with earnings growing at 15%, 20% and 25% per annum respectively:
As you can see, you would have made more money buying shares in company C than by investing in company A or company B. This assumes that all the companies remained on the same multiples. There would even be scope for the multiple of company C to drop from 25 to below 20.4 after five years or 16.6 after ten years before an investment in that company made less than an investment in company B.
I suggest that you stick with my rule-of-thumb measure and as a first step always simply compare the P/E ratio with the growth rate. The former should be less than three-quarters of the latter. You are seeking shares with a prospective PEG of not more than 0.75 and preferably under 0.66, but when the growth rate is at the high end of the range and all your other criteria are met, you can be a little more flexible.
Bear in mind that, all other things being equal, a share with a PEG of one is still a bargain. Over the last fifty years you would have fared exceptionally well by buying the market index on a PEG of one. However, you are not interested in the market as a whole – you are looking for the best shares within the market at absolutely bargain prices. Finding shares like these will ensure that you have the maximum chance of capital appreciation, and will at the same time provide you with an important safety factor. As we have seen, stocks with very high P/E ratios can fall a lot further than those on lower multiples.
Do not under-estimate the PEG factor as a measuring instrument and as a very important investment tool. Let me give you another example of how well it works in practice. In December 1990, Analyst recommended Domestic & General.
As you can see, there were excellent prospects for substantial growth in earnings per share. Analyst’s estimate for 1991 was for an increase of 36.4% and for a further increase of 17.5% for 1992. The price in December 1990 was 363p giving an historic P/E ratio of 11.6 and a prospective P/E ratio of only 8.5 on a conservative view of future earnings growth of 20% per annum. Both the historic PEG and the prospective PEG were exceptionally attractive at 0.58 and 0.42 respectively.
The calculations are very simple:
By the end of 1991, the shares had soared from 363p to 1000p and the PEG had increased from 0.42 to 1.18 – still not expensive for such an exceptional growth share near to the end of its financial year. The 1992 prospective PEG would be at least 20% less and still be relatively attractive at under one. Note carefully that 70% (446p) of the increase in the share price from 363p to 1000p was due to the change in status -the change in the P/E ratio, not the increase in earnings per share.
You can see from these calculations that a critical factor is the estimated future growth rate. The past results are history but the future has to be a best guess. The Chairman’s statement on the future outlook helps both at the year end and half-yearly. The ‘body language’ of the Chairman is also important. Be very wary if he sounds a note of caution. Furthermore, if the dividend has been increasing regularly, be on the alert if one year it is simply maintained.
The most reliable indicator for the future is probably the brokers’ consensus estimate of future earnings. The Estimate Directory is an excellent publication which contains details of all brokers’ estimates and your broker ought to have these at his fingertips. The important point about the consensus of brokers’ estimates is that they are frequently based upon analysts’ visits and should give you a very good feel for the future earnings potential of a company. Occasionally, you will be disappointed, but sometimes you may have a very happy surprise.
You should also be vigilant for press comment on anything the Chairman says at the AGM, to analysts or to the press throughout the year. Your broker should always let you know if there are any important developments, but not all announcements are given formally to the Stock Exchange. Most brokers subscribe to a press cuttings service. From time to time, it is worth checking with your broker to see if you have missed anything in the Investors Chronicle, Financial Times or the other newspapers and stock market newsletters that you read.
If you have invested in a company growing steadily each year, your main concern should be any slowing down in the rate of growth. There are few worse investments than a growth share going ex-growth. Any sign that the Chairman has become less optimistic or that things are not going according to plan will, almost certainly, be a good reason for you to sell your shares.
In the UK very few companies announce quarterly results. We have to rely upon half-yearly statements to measure progress and find out if there has been any variation in the earnings growth rate. Before making a final judgement, we must first make allowances for a few vital factors:
You are seeking shares with an earnings growth rate of 15% per annum compound or more and a prospective PEG of not more than 0.75 and preferably less than 0.66. They are few and far between, but if you are selecting a team of cricket players you want a few stars like Botham and Gooch – not everyone who plays cricket. So be patient and keep looking until you find a share that really fits your criteria.
Remember that, ideally, you want there to be recent acceleration in the earnings growth rate. A company with a shorter record than five years might qualify, if there was new management with two or three years’ evidence that substantial progress was being made. The key point is to look for companies that are still in a dynamic growth phase.
The New Issues market can be a very productive source for finding companies that are growing much faster than average. Take, for example, Sage, the computer software supplier which was floated in December 1989 at 130p per share on a prospective multiple of only seven times earnings. I kept an eye on Sage after the flotation and noticed how cheap the shares were when they were reviewed in the Investors Chronicle a year later.
Let us examine Sage in more detail. You will quickly see how well the statistics fulfilled my criteria:
Earnings per share grew as follows:
1990 was the first year as a public company but the Investors Chronicle article gave the full five year record. The earlier years would also be obtainable from the prospectus.
Although 1990 earnings did not increase at the same rate as the previous three years, 50% is still a phenomenal growth rate for a company of Sage’s size.
At 203p, the shares were priced at less than 11 times 1990 earnings and at less than 9 times estimated 1991 earnings. Although the growth rate looked like slowing to a more sustainable 25% per annum, the shares were still obviously very cheap with an historic PEG factor of only 0.44 and an astonishingly low prospective PEG factor of 0.36.
In December 1990, the Chairman said ‘In the first two months of the current year, we have exceeded our internal targets. Despite the hostile business environment, we are confident that 1991 will be another year of continued growth.’ You could hardly ask for more.
Strong cash flow and £5.5m of net cash, amounting to 17% of market capitalisation, easily satisfied this criterion.
A successful strategy coupled with a high level of advertising meant that Sage was continuing to increase market share and margins, despite very difficult conditions generally. Sage had about 40% of the market in small business software in the UK and was growing in the US. There were also many opportunities opening up in the Third World and Eastern Europe.
The financial difficulties being experienced by the company’s main rival, Pegasus, were helping growth of market share in the UK.
At 203p the market capitalisation was a very attractive £33.1m.
The Datastream graph of relative performance against the FT-A All-Share Index is clearly very positive.
The yield was a very satisfactory 4.6%. 1990 was the first year a dividend was paid as a public company.
Negligible tangible assets, although £5.5m in net cash. The company also has valuable intellectual properties.
Directors owned 37% of the shares worth more than £12m, giving them the owner’s eye.
Between December 1990 and May 1992, Sage shares rose from 203p to 469p, a gain of 131 %, compared with the market average of 25%. Although Sage beat their forecast and earnings grew by a highly satisfactory 33% in 1991, the main contribution to the gain in the share price of 131% was the substantial increase in the company’s multiple. The lower the prospective PEG at the time of purchase, the more scope there is for a dramatic upwards status change. The examples of Sage, Domestic & General and MTL Instruments illustrate how earnings growth and a status change in the multiple work in tandem to provide astute, systematic investors with exceptional gains. You can see how well the system works.
A further very important factor in buying a rapidly-growing stock, and in judging whether or not the P/E ratio is expensive, is the exact timing of your purchase. Let us return to MTL Instruments and assume that you had invested in the shares one month earlier. The price of the shares in February 1991 was 124p, and earnings per share in the last reported year to December 1989 were 11.3p. Therefore, you would have paid 11 times historic earnings and bought the shares on a prospective P/E ratio of 9 for the year ended December 1990. One month later in March 1991, the results for 1990 were announced. You would have known from the half year results that the profits were going to be excellent, but in February 1991 many investors were still valuing the shares on the historic multiple. The forecast for the following year, 1991, was optimistic, enabling analysts to estimate confidently that there would be a further 20% uplift in earnings. Within a few weeks the market began to think of the company on a prospective P/E ratio for 1991, which made the shares seem to be far cheaper than they were at the time of your purchase. When a baton is passed in a relay race attention focuses on the next runner and the next lap – moving from the historic to the prospective P/E ratio.
By purchasing fast-growing shares near the end of one financial year (or half year) you frequently enjoy a one-off gain as the market adjusts to absorb the results of the previous year and digests the news that next year should be even better. This process is aided by the press and by brokers, as relatively obscure companies receive very little press and broker comment throughout the year, often only having their moment in the sun when their results are announced.
1. Increased earnings per share over the last five years at a compound rate of about 15% per annum or more. A shorter period is allowable when there is a recent acceleration in earnings, preferably with an easily identifiable and sustainable source such as new management.
2. A P/E ratio that is very attractive in relation to the growth rate with a target of a prospective PEG of not more than 0.75 and preferably under 0.66. Put another way, the prospective multiple should be not more than three-quarters of the estimated future growth rate and should preferably be under two-thirds.
3. A P/E ratio that is attractive in relation to the past history for the company, the average for the industry and the average for the market as a whole.
4. The chairman’s yearly and half-yearly statements must be optimistic in tone and the dividend policy must be consistent with this. The market consensus of profit forecasts must also be optimistic.
1. The price of growth shares can only increase due to earnings growth and a status change in the multiple. The latter is often much more important than the former.
2. Avoid stocks on astronomic multiples.
3. When considering the half-yearly results pay particular attention to seasonal factors and bear in mind that some stocks traditionally have a better first six months.
4. Beware of confusing cyclical stocks in a recovery phase with growth stocks. Cyclical stocks are the subject of a separate system in a later chapter.
5. Fast-growing shares can often be purchased advantageously just before they announce their yearly or half-yearly results, when attention will shift from the historic to the prospective P/E ratio.
Now that you have a better understanding of earnings, growth rates and the PEG factor, we must spend some time on fine tuning.
In the last chapter, I elaborated upon the first three criteria of my system for investing in dynamic growth shares. To keep the explanations as simple as possible, I resisted the temptation of distracting you by suggesting that the earnings of a company may not be all that they appear. Now we come to fine tuning and must look at the dangers of taking annual earnings at their face value:
Some members of the accountancy profession might argue that accounting is an exact science. Others see the presentation of Balance Sheets and Profit and Loss Accounts as more of an art form. Despite all the Institute of Chartered Accountants’ recent efforts to improve accounting standards, there is still no doubt that a resourceful Finance Director has a considerable degree of flexibility in portraying his company’s results. Financial creativity is easier in some industries than others, but in most businesses there is plenty of scope for an imaginative approach.
The Financial Reporting Council has stated that accounts should not only be true and fair but also informative. The Council goes on to say that no pressures can justify companies taking advantage of opportunistic developments in financial practice to window-dress accounts. The sentiment is laudable, but enforcement will be extremely difficult.
Various accounting bodies – the Accounting Standards Board (ASB), the Financial Reporting Council (FRC), the Financial Review Panel (FRP) and the Urgent Issues Task Force (UITF) – are working hard to improve standards, so this chapter might be a little out of date by the time you read these words. I can only give you a snapshot overview of the present position and make you aware of some of the problems you would have faced in June 1992 in determining, from a set of accounts, a true picture of the earnings growth of a company.
The simplest example of creative accounting is an invoice for services rendered which can be issued just after or just before the end of a financial year. As a result, profits will either be depressed or boosted according to the whim of the person making the decision.
Take another instance – a company in the building business which has an unsold house in the books at the end of its last financial year. The house could have been built during the first six months of the year at a cost of £100,000, and the estimated selling price might be £200,000. Accounting prudence demands that at the end of the year the house should be valued for accounting purposes at cost or market value whichever is the lower. On the first day of the current financial year, the house could be sold for the full asking price of £200,000 and alakazam, the profit of £100,000 would be brought into the current financial year, not the previous one. There is nothing sinister in this. The profit will not be made until the house is sold, but one day can make all the difference to the annual profits. You can readily see that many an entrepreneur anxious to preserve his company’s unbroken record of earnings per share growth would make every effort to sell the house in a year in which profits were poor. Conversely, if business had been excellent and the future outlook appeared murky, our entrepreneur might deliberately delay a sale by a few days to swing the profits into the more difficult period ahead. I have illustrated my point with only one house but there could be many. In some businesses, several million pounds could easily be shunted from one financial year to another with this kind of approach.
Provisions are another area which offer scope for transferring profits to another year. Let us assume that our entrepreneur has had a good year and wants to tune down his company’s profits a little. When reviewing the outstanding debtors he simply decides to adopt an exceptionally cautious view over the amount to be provided for bad debts.
Unless he is blatantly and obviously wrong, the auditors are unlikely to challenge his prudence. Similarly, he might argue that a more substantial provision should be made against the value of old stock and work in progress. These simple examples show how profits can be transferred from one year to another either intentionally or fortuitously.
Any qualification of the Auditor’s Report can be a sign that the company is heading for trouble. You must also be on the alert for proposed changes in the company’s auditor, especially from a leading firm to a small and obscure one. These are obvious warning signals; more subtle ones emerge from studying the methods some companies use in other areas of accounting that lend themselves to inventive treatment:
Development costs may be deferred to future periods in respect of defined projects, the outcome of which can be assessed with reasonable certainty as to their technical feasibility and commercial viability. Otherwise all research and development costs should be written off in the financial period during which they are incurred.
This is the guidance given in Statement of Standard Accounting Practice (SSAP) 13, which goes a long way towards preventing manipulation of Research and Development costs between one year and the next. However, even this kind of definition cannot be sufficiently precise. The words ‘reasonable certainty as to their technical feasibility’ offer scope for an opinion as to what is or is not ‘reasonable’. The final view could easily be coloured by an entrepreneur trying to improve profits or hold them back.
In June 1992, there was no SSAP or other definitive guideline about the treatment of advertising expenditure. The normal conservative accounting approach is to write off the expenditure as incurred. An equally acceptable alternative in the case of a major campaign for a new product is to write off the expenditure over several years. The Finance Director’s opinion is all-important. He in turn has to persuade the auditors that his ideas are correct. Any unusual treatment would have to be disclosed in the Accounts. On this subject, companies often have very different accounting policies so investors should read the detailed Notes to the Accounts very carefully.
Polly Peck was the most notorious perpetrator of boosting profits with currency transactions. A large amount of money was borrowed in hard currency like Swiss francs at a cost of say 7% per annum, and invested at a much higher rate of say 20% in a weak currency. The difference of 13% per annum was brought into the accounts as a profit. On the other side of the coin, the weak currency depreciated in value during the year by say 15%, but this was shown as a reduction of capital in the Balance Sheet. There was a note in the Annual Report under the heading of Accounting Policies stating that ‘The effect of variances in the exchange rates between the beginning and end of the financial year on the net investment in subsidiary companies is dealt with through reserves.’ Easy to see with hindsight.
The UITF has recommended that re-organisation costs should in future be presented as exceptional, and charged against earnings per share, unless they result from the closure of a segment of a special part of the business sufficiently large to have its own management accounts. Previously, re-organisation costs could be written off as an extraordinary item, with the result that earnings per share were not affected.
Conglomerates and acquisitive companies (one of which I managed for a while!) have taken advantage of the earlier rules by making massive provisions for future re-organisation costs. These were shown as an extraordinary item, as they were for future costs which obviously could not be charged against the current year and would be difficult to allocate against individual future years. The effect of making too large a provision for future costs was, of course, to increase future revenue profits. Many future expenses could easily be classified as part of the re-organisation and charged against the provision instead of the year’s profits.
Last-in-first-out (LIFO) is more conservative in inflationary times than first-in-first-out (FIFO). A change of method will be highlighted in the accounts and the effect should be noted carefully.
Some methods are faster than others, so always look to see if there is a change and whether or not the company’s earnings have obviously benefited as a result. In the year of the change this should be easy to spot.
The profit or loss on the sale of a fixed asset is part of the company’s ordinary operations. If particularly large, it should be shown as exceptional. A profit or loss arising on the sale of a business or part of a business is also now regarded as an exceptional item and should be taken into account in calculating earnings per share. You will have to make your own judgement on whether or not you consider such a profit or loss to be a true part of the company’s earnings for the year in question.
Normally interest is charged against profit, but on occasions the interest cost of a particular project is added to the capital cost. The use of this technique flatters both the asset value in the Balance Sheet and the profits in the Profit and Loss Account. Obviously, there is considerable scope for abuse, especially by over-geared property companies anxious to reassure their bankers and loan stockholders.
Companies frequently finance acquisitions by making a down-payment to be supplemented by a subsequent payment, in either shares or cash, based upon a multiple of profits to be made during the next few years. The future liability is not usually shown clearly in the accounts and in earnings per share calculations. If the share price has fallen drastically by the time the final payment is due, this can result in very substantial dilution. In these circumstances, any heavy cash liability might also be difficult to fund.
Potential liabilities for deferred consideration will be shown in the Notes to the Accounts under a heading of that name, Financial Commitments, Contingent Liabilities or something similar. Be vigilant!
By changing a financial period, year to year comparison of earnings growth is made more difficult. With most companies there will be a good reason for doing so but on occasions the motive might be more covert. You must be alert to this possibility.
Your main concern is to try to establish the annual growth rate of a company’s earnings per share. Extraordinary and exceptional charges muddy the water and make an analyst’s task far more difficult. Almost all of these are part of the cost of being in business. A strike or a very large, unexpected bad debt might be classified as exceptional, but strikes and bad debts happen in business very frequently indeed.
Before you accept the earnings per share figure, you must examine each exceptional item in detail to see if any profits should be eliminated. You should also look at the items charged as exceptional expenses in case any of them should be added back to increase profits.
Extraordinary items should become very rare under the proposed new recommendations outlined in a Financial Reporting Exposure Draft (FRED 1). Major changes in the format of the Profit and Loss Account are also proposed. If adopted as a new standard, group accounts would have to separate the results of continuing operations from discontinued ones; segregate acquisitions and unusual items; abolish extraordinary items in almost all cases; explain reserve movements; and disclose revenue investment. Extraordinary items are now defined as those which derive from rare events or transactions that fall outside the ordinary activities of the company. A further important proposal in FRED 1 is that earnings per share should be calculated after extraordinary items, which should be disclosed on the face of the Profit and Loss Account. Companies may also show earnings per share calculated in a different way, provided the basis is consistent, clearly explained and reconciled with the earnings presentation proposed by FRED 1. In other words, the Directors can attempt to show a truer earnings picture for the year, provided they explain exactly what they are doing.
There are substantial differences in accounting standards between the UK and the US. Standard setting in the US began in 1930 whilst in the UK the accountancy bodies only began issuing SSAPs in 1970. The US standards cover practically all conceivable accounting alternatives and have been recognised as authoritative by the SEC and the US courts. In the UK, it is only since the formation of the ASB in 1990 that standards have begun to have statutory implications. Directors can now be forced to pay for the reissue of accounts that do not meet the required accounting standards. Board members beware – the ASB is looking for scalps!
Where does all this leave the investor? The rules of the game are being tightened, but meanwhile you have to make judgements of earnings per share and growth rates. How extraordinary is extraordinary, and how exceptional is exceptional must be your constant questions. Earnings per share will in future be shown after extraordinary and exceptional items, which will be clearly explained. Your task will be to decide if any of them should be added back or eliminated to give you a truer picture of the growth prospects.
Ben Graham, the well-known American investor, suggested that auditors should make their best guess for apportioning exceptional items over a period of years. In this way, earnings per share would be much more related to individual years and growth would be easier to calculate. Graham also suggested taking the average of the last three years’ adjusted earnings and comparing them with the average of another three year tranche of adjusted earnings from say five or ten years earlier. This would help to smooth out the effect of extraordinary and exceptional items. Certainly, there is something to be said for working on averages, especially for conglomerates and other highly acquisitive companies.
One of the most reliable cross-checks on earnings is a company’s cash flow during the same period . In 1991, for instance, ICI had trading profits of £1bn and excellent operating cash flow of £1.5bn. In contrast, British Aerospace had profits before tax and exceptional items of £154m, and operating cash inflow of minus £95m. A prize also goes to Polly Peck, which in its farewell set of accounts showed pre-tax profits up 44% at £161m – but in the new style of cash flow statements, County Nat West calculated that the operating cash outflow would have been £129m. The main reason was a staggering increase in working capital of £288m. When there is a large divergence the wrong way, you will know that creative accounting has been at work.
Whatever else you do, keep an eye open for profit boosting by the methods I have mentioned, cross-check with cash flow and always read the annual report and accounts from beginning to end. Remember that footnote 34 (d) or even 63 (c) might contain a very important message for you.
Any calculation of earnings per share should allow for convertible loan stocks, bonds and preference shares being converted and options and warrants being exercised. Where these total less than 10% of the shares in issue, they are not worth complicating your thinking, so I suggest that you ignore them. The conversion of a loan will save some interest, and the exercise of warrants or options will bring fresh cash into the company. There would be a little dilution of earnings but not enough to worry about.
Occasionally, a company has a massive convertible which definitely distorts the earnings picture and cannot be ignored. For example, in April 1990, Owners Abroad took over Redwing Holidays from British Airways and issued a convertible for £17.25m to fund the purchase. By the end of 1990, Owners Abroad had over 27 million of the convertible preference shares in issue. At a conversion price equivalent to 65p a share they would convert into just over 41.7 million ordinary shares (153 ordinary shares for every 100 convertibles) between April 1991 and the year 2000. To calculate maximum potential dilution, you have to assume that all will be converted. You therefore add the 41.7 million potential additional ordinary shares for conversion of the preference shares to the 5.95 million for options, and add the total to the average number of shares in issue during the year. In this case, the increase would be just under 40%.
For a rough guide to see how this would affect earnings per share, you simply divide the new total into forecast profits after tax. However, for a more accurate result, you should take into account the potential dividend or interest saving, as the company, after conversion, will no longer have to pay the preference dividend or loan stock interest.
Fortunately the calculations are usually made for you. All the options and convertibles are shown in the Notes to the Accounts under the heading of Called-up Share Capital or something similar, and the potential effect of reinvesting the proceeds is shown under Earnings Per Share.
As you can see, dilution can turn out to be significant with a consequent depressing effect on the growth of earnings per share. When the number of shares to be issued on conversion is more than 10% of share capital, you should make the necessary calculations to gauge the effect. Needless to say, the lower the conversion price, the more likely it is that convertibles will be converted.
Frequently, companies have tax losses brought forward and available to set off against current profits. This can result in an abnormally low tax charge for the year during which the tax loss is used. Earnings per share growth is based upon earnings after tax. The tax charge should therefore be adjusted back to a normal level to obtain a true picture. Companies operating in enterprise zones and companies in Ireland often enjoy tax breaks and receive capital grants. Heavy capital expenditure in some engineering and leasing companies also lowers the tax charge. You should adjust the tax charge to a normal level if the tax break is unlikely to recur.
Take a company with a normal tax rate of say 33.3%. If profits before tax were £12m and net earnings after tax were £10m, that would mean that for some reason the tax charge had been reduced to only 16.7%. If this exceptionally low tax charge appeared to be due to a one-off happening, you would simply deduct 33.3% from pre-tax profits of £12m, to give you revised net profits of £8m upon which to base your earnings per share calculations.
It is very important to distinguish between companies that regularly pay lower tax and those that have benefited from an isolated, non-recurring event.
We can now move on to the first of my protective criteria, which, taken together, will form a safety net under any shares you buy.
Since writing this chapter, an excellent book on the subject of creative accounting has been published. Accounting for Growth by Terry Smith gives, among other things, a comprehensive account of the many ways of boosting a company’s earnings per share growth. If you are seriously interested in mastering the complexities of company accounting, you should read this book.
Icould have simply entitled this chapter ‘A Strong Financial Position’ but I wanted to highlight liquidity, cash flow and borrowings as three very important and distinct factors.
The word ‘liquidity’ refers to assets that are ‘easily converted into cash’. The assets in question are usually short-term loans, debtors (less creditors), gilts, quoted investments and, of course, cash. The word ‘easily’ means ‘free of pain or trouble’. In a deep recession, debtors could be much more difficult to convert than you might expect (ask any bank) but we will proceed on the basis that the financial climate is reasonably normal.
Obviously, a company is in a strong financial position if it has substantial cash balances and no debt. Provided that the strong liquid position has been achieved by organic growth, this must be taken as excellent prima facie evidence that the company is a cash generator of a high order.
Now let us look at a less fortunate company with cash balances of say £1m but debt of £5m. We will assume that the £1m has not arisen from a recent rights issue or other funding of a similar nature. The key questions are: how pressing is the debt, and is the company truly a cash generator? The debt will be classified in the accounts between that falling due within one year and longer term obligations. In this case there might be an overdraft of £1m and a mortgage on the company’s main property of £4m. If the mortgage is short-term you might decide to move on to another company, but if it is long-term your due diligence should continue.
Another useful way of checking a company’s soundness is the ‘quick ratio’ of current assets, less stocks and work in progress, to current liabilities. I like to see current assets less stocks at least 1.5 times current liabilities, but I would accept less (possibly down to 1 to 1) if everything else seemed to be in order. The higher the ratio the better. You will discover later when reading Chapter Thirteen on ‘Value Investing’ that Ben Graham’s disciples’ main criterion used to be finding companies selling at a discount to their net current asset values. There are very few of these around nowadays, but a strong net current asset position is a highly desirable investment criterion to add to your repertoire and strengthen your safety net.
Another useful measure is the overall debt to equity ratio of a company. Equity in this case is the net asset value attributable to ordinary shareholders. This sounds simple, but beware – professional investors seem to have many different interpretations of the meaning of the words ‘net asset value’ and ‘overall debt’. My method is a harsh one by some standards – I only take the tangible assets, so I deduct goodwill from the total balance sheet figure. To calculate overall debt, I add all the creditors of over one year to the bank overdraft, add any short-term loans and hire purchase and finance lease obligations. Then I deduct surplus cash and express the resultant total as a percentage of the net tangible assets. Let me show you how this worked with a May 1992 new issue, Industrial Control Services Group plc.
First turn to the pro-forma balance sheet, which shows net assets after the placing of £17,116,000. Deduct intangible assets of £472,000 to give net tangible assets of £16,644,000. Now take all interest-bearing liabilities falling due after more than one year, £6,350,000 (£6,564,000 less £214,000 accruals) – this figure includes mortgages together with some finance leases and hire purchase obligations. Then turn to creditors falling due within one year (see overleaf) and extract interest-bearing current instalments on bank loan of £64,000, bank overdraft of £6,054,000, other loans of £1,000,000 and hire purchase contracts of £331,000. The total of these figures is £7,449,000, from which you should deduct cash in the pro-forma balance sheet of £6,104,000 and the £1,000,000 that has been repaid to creditors after the placing.
The following pro forma balance sheet of the ICS Group is provided for illustrative purposes only and is based on the audited consolidated balance sheet of the Group at 30 November 1991, adjusted as set out in the following notes.
Industrial Control Services Group PLC pro forma balance sheet
Notes:
1. Adjustments have been made to reflect the special resolution passed on 18 May 1992 to reorganise the share capital of the Group and the excercise of the share warrant by 3i. For further details see paragraphs 1.3 and 1.4 of the section headed ‘Further information’ on page 49.
2. It is assumed that the placing proceeds net of expenses will be £6.6m.
3. The impact of the results of the Group after 30 November 1991 has not been taken into account.
The resultant figure is £345,000, which added to the £6,350,000 of creditors due after one year gives ‘overall debt’* of £6,695,000. The percentage of net debt to equity is calculated as follows:
My limit for growth companies is 50% so this is just acceptable.
You need not worry too much about having to make the calculation of the net debt percentage. The Investors Chronicle adopts a similar method to mine and always highlights the figure in its reviews of company results.
There seem to be several other anomalies in calculating net debt. For example, I would have thought that a dividend due within a month of the accounts being published should also be classified as debt. The payment will increase the overdraft or reduce the cash balance so if the snapshot was to be taken only one month later, debt would undoubtedly be higher. Similar remarks apply to the tax liability, although this would not have to be paid so quickly. When I stop to think about this problem, I also wonder about capital commitments which will in some cases soon become part of overall debt. If you really want to get down to fine tuning you have to be aware of all of these points, but to keep your approach simple I suggest that you only bother about them when the overall debt figure is marginal and you are beginning to feel uneasy about the company.
Another contentious area seems to be convertibles. If the share price is well above the conversion price there is an argument for ignoring them when calculating overall debt, especially if the conversion date is near. If the conversion price is miles above the share price, the convertible must be classified as debt, as any Ratners shareholder will confirm. In the middle ground, when the share price is near to the conversion price, the prudent course is to classify the convertible as debt.
Ideally, we are seeking growth companies with net cash, so remember that any debt is already the beginning of a compromise. Up to a 50% net debt position can be tolerated if all of our other investment criteria are well and truly satisfied.
Occasionally, you will be unintentionally misled by companies that are in businesses like construction which receive large deposits in advance of major contracts. I remember that Whessoe, for example, had a rights issue in 1991 to fund an overseas acquisition. Although the company seemed to have a strong cash position at the time, the board rightly pointed out to shareholders that much of their cash was not free as it represented deposits made by customers in advance of substantial contracts.
Moving on now from the present position of a company to future cash flow, we need first to define the term. Cash flow is the net amount of money a company generates during its financial year. To calculate net cash flow, you add back to the net trading profits those items requiring no cash outlay. The main one is of course depreciation.
Conversely, the profit retained by an associate company that has been equity accounted has to be deducted from net trading profits. For example, if the company under review held 20%, with board representation of an associate which had made a profit of £10m after tax, the annual net profits figure of the group would include a pro rata contribution of £2m. The associate may, however, only have paid a dividend of a quarter of that amount, and therefore in cash terms only £500,000 would have been received. The retained balance of £1.5m would have to be deducted from profits to determine the operating net cash flow for the year.
In an attempt to make the investor’s task easier, the Accounting Standards Board now has a new mandatory requirement for a Cash Flow Statement in place of the old Statement of Sources and Applications of Funds. The new statement splits cash flow into different categories and attempts to classify sources of movements into their economic causes. Future headings will be: net cash inflow from operating activities, returns on investments and servicing of finance, taxation, investing and financing. There is a mass of figures, so focus upon the most important single point – the net cash inflow from operating activities should not be materially different from the profit arising from trading operations . The accounts of Sainsbury for the 52 weeks to 14 March 1992 illustrate very clearly how easy it is to reconcile operating profits with net cash inflow from operating activities. In the Group Cash Flow Statement you are immediately referred to Note 24 which is set out below:
As you can see the operating profit is £667.7m from which £49.4m is deducted for the retail employees profit sharing scheme. There is then a very substantial £135.6m added back for depreciation which, although charged against profits, does not absorb cash. The rest of the adjustments are related to working capital requirements – increases or decreases in stocks, debtors and creditors.
The final result is a healthy £788.8m net cash inflow from operating activities , which compares very favourably with the £667.7m of operating profit . Many reports and accounts are not as well set out as Sainsbury. The less clear they are the more vigilant you should be. Concentrate upon the key figures. When operating profit exceeds net cash inflow from operating activities , you know that creative accounting has almost certainly been at work.
Why is cash flow so important? First, as a check that trading profits and therefore earnings are in order, and second, because free cash flow funds the expansion of a company. By the term ‘free cash flow’ I mean cash flow after dividends and after capital expenditure. Good examples of businesses with excellent cash flow are food retailers like Sainsbury or Tesco. They need very little capital to open a new supermarket – the property can be rented and stocks of food financed by suppliers. From the opening day the tills ring up disposable cash. Bread, for example, is supplied on credit by the bakers, sold for cash and eaten within a day or so. A few weeks and in some cases months later, the baker’s account is settled by the supermarket, which has enjoyed the use of the cash in the meantime. At the end of its financial year the cash profits of a supermarket are spent on taxes, dividends, the repayment of debt and of course on new supermarkets to generate further growth. The only worry is when over-expansion and over-building causes conditions to become so competitive that there is a price war. They rarely last for long though – why spoil a good thing?
I was never quite sure why Jimmy Goldsmith attached so much importance to brand names like Bovril and Marmite, and why when making his early fortune, he concentrated upon food retailing with Allied Suppliers in the UK and Grand Union in America. I have now caught up with his thinking. I hope to show you how to invest in companies like these – companies that enjoy a competitive advantage, a high rate of return on capital employed and a strong cash flow, which is not eaten up by capital commitments of a negative kind.
Capital expenditure falls into two main categories. The first is the replacement of an old asset such as plant and machinery, which is in a bad state of repair or has become obsolete. This is more in the nature of maintaining the status quo – an essential cost to stay competitive. The second category of capital expenditure is far more up-beat – a brand new, additional factory, together with the most modern equipment – the stuff that makes for real expansion. You will find that there are some businesses, like steel companies, that have to invest every year in plant and equipment. Their shareholders rarely benefit.
Companies with very strong business franchises are more fortunate. They can invest in new products, new technology and new businesses, all of which should help to increase, as opposed to maintain , annual profits.
Something new is a highly desirable but not absolutely mandatory criterion for investment. Companies with excellent brand names, like Glaxo and Cadbury Schweppes, and well established companies in niche markets like Rentokil, continue to churn out increased earnings per share at well above average rates year in and year out without the benefit of anything new. They may add a new product or service to their range, but nothing dramatic – nothing that in itself would cause earnings to soar. Knowing that I might find another growth share like Glaxo or Rentokil, I do not insist upon any new selection of mine benefiting from something new, provided that most of my other investment criteria are met. However, when I do find a share that has all the right fundamentals and the added advantage of something new, that really gets my taste buds going. So often, the new event or product is a wonderful confirmatory bonus explaining the increased earnings potential and high relative strength of the shares.
There are four main categories of new factors which are of sufficient importance to have a major impact upon share prices:
New management is the most important of all. The reason is simple – the impact of excellent new management can be both far-reaching and on-going. If new managers of calibre take control of a company, their efforts are likely to bear fruit for many years to come.
Two of the many well-known examples are James Hanson and Gordon White, who joined the board of Wiles Group, and Greg Hutchings, a senior executive of Hanson who joined F.H.Tomkins. The Wiles Group became Hanson and has grown from under £2m to over £11bn during the following twenty-eight years; Tomkins has grown from £6m to £1.4bn during the nine years since the arrival of Greg Hutchings. The benefits of these management changes continued for many years and are still continuing today.
The gains from a new product or new technology can also be ongoing. For example, in October 1981, Glaxo launched a new patented product, Zantac, for the treatment of ulcers. By 1991, the sales of Zantac totalled £1.6bn. At the time of the launch, it would have been difficult to anticipate the worldwide success of Zantac, but shortly after 1983, when the product was approved for use in America and broke all records for a new drug there, any intelligent investor could have enjoyed a massive capital gain. The sales of Zantac are levelling off now but the product continues to make a major contribution to Glaxo’s profits.
Psion’s new palm-top computer, the award winning star of a leading international computer show in America in 1991, should have a major impact upon Psion’s future sales and profits. However, in the fast moving computer industry there will always be the worry of a competitor developing something better. Products of this kind are hard to patent and the key factor is the length of lead time. Companies like Psion have to make hay while the sun shines. It is important for you to distinguish between patented new products and those that can be more easily displaced by market forces.
Sometimes a new product might be a tremendous success but will have little impact upon the company’s earnings due to the relative unimportance of the new product within the group. I am sure that Sony benefited from the Walkman, but the success of that product did not transform Sony’s already massive profits. In contrast, Nintendo benefited far more directly from the success of its video games. Your task is to use your best judgement to determine whether or not a new product will be a winner and to evaluate its likely effect upon a company’s earnings. This is not always easy, so I suggest that when looking for something new you only consider products that obviously constitute a substantial proportion of the company’s business, are central to the main activity and will have a major impact upon future earnings. For example, Polaroid in America had one of the best new ideas of this century with a new instantly developed photograph. The company subsequently invented a colour version and as a result in the sixties the stock multiplied in value many times. A good proportion of the world’s population must have realised that Polaroid had something new, that it was a major part of their business and that earnings would benefit for many years to come.
The other consideration for a new product is to distinguish between gimmicks that will have a short life and those that might last indefinitely. In the toy industry Barbie has been alive and well for fifty years, but the Wombles of Wimbledon are now long forgotten. Teenage Mutant Ninja Turtles are one of the latest crazes, but I would not award them a high multiple.
New events in an industry would of course include the collapse of a main competitor. The failure of Harry Goodman’s International Leisure Group made life easy for Owners Abroad, Airtours and the rest of the holiday business. The finding of oil in the North Sea obviously benefited many oil rig suppliers and property and service businesses in the City of Aberdeen. Wars benefit companies in the defence industry. A change of government could influence the future level of spending on hospitals, and fresh legislation on the disposal of waste and the cleaning up of the environment could have far reaching effects upon companies connected with that industry. The planned opening of the Channel Tunnel has already been a major influence upon the value of property in Northern France and the South of England. German reunification gave a massive boost to consumer demand benefiting most of West German industry, especially automobile manufacturers. There are hundreds of other examples.
From now on try to think about events in this way. As you read the details of a major new development or product, make a conscious effort to decide whether or not it is likely to be a long-term winner and consider the probable effect upon the shares in your existing portfolio and any future selections you might have under review. When you first heard about video recorders, you would almost certainly have concluded that they would prove to be a worldwide success. Your difficulty would have been to select a particular company that would benefit. Most major electrical manufacturers produced their own video recorders so the benefits were spread thinly throughout the industry. This is frequently the case unless a product can be patented – a vital factor that you should always bear in mind.
Unlike new management and a patented product, some new developments, such as the collapse of a major competitor, only have a short-term effect. Obviously, there is an on-going benefit, but the major impact comes during the first year, and the acceleration in earnings in that year may not be repeatable.
A new acquisition can often have a major impact upon a company’s earnings and status. When Hanson took over Imperial Tobacco, the company instantly became a major part of the fabric of British industry, with enormous cash flow and financial strength. Of course, Hanson was a great company before the acquisition, but afterwards it was regarded in a different light.
I give below a few examples of something new from each of the four categories with graphs showing how the shares reacted subsequently:
(i) English China Clays – Andrew Teare’s appointment as Chief Executive of the company in the summer of 1990 has had far-reaching results for the group. He has since disposed of non-core assets totalling £110m to concentrate upon the core activities and made a £310m acquisition of a china clays business in the USA. By June 1992, the share price had doubled from its autumn 1990 low.
(ii) Kalon Group – Since Mike Hennessy from Dixons moved in as Managing Director in February 1988, losses have been eliminated and £17m of debt has been repaid. 1988 profits and earnings per share have increased nearly 150% despite the recession, and net cash stood at £12.8m at the end of the last financial year.
(iii) Weir Group – During the early 1980s, Weir was losing £10m per annum and looked like becoming a victim of that recession. Since Ron Garrick’s appointment as Managing Director in 1982, the group has been slimmed down to two core divisions and the workforce has been slashed. Profits have grown steadily in recent years, exceeding £30m in 1991. The dividend has trebled during the last five years.
(i) Wellcome – The development of Retrovir for the treatment of AIDS helped the company’s profits to soar after the product was launched in March 1987. The drug enjoys high margins and is forecast to keep expanding sales for many years to come.
(ii) Racal Electronics – The extraordinary success of the Vodafone business, launched in 1985, has done wonders for Racal’s share price. Vodafone was floated off as a separate company in September 1991, valued at £3.5bn.
(iii) Microsoft – An American NASDAQ company which revolutionised the computer industry with its highly popular ‘Windows 3.0’ software in June 1990. Two years later Microsoft was capitalised at $20bn.
(i) Sage Group – The financial difficulties of Pegasus, its main competitor in the UK, helped Sage to secure 74% of the accounting software market for small companies and 43% of the total small business software market.
(ii) Pentland Group – Bought in 1981 for a mere $77,500, a substantial stake in Reebok became worth more than $700m on the back of a swing towards sports shoes as fashion accessories and the craze among American women for Reebok’s specially designed aerobics shoes. As the investment in Reebok soon became Pentland’s main asset, this new consumer trend had a massive impact on Pentland’s share price.
(iii) Sainsbury – In the early eighties, the acceleration of the trend towards out of town shopping and hypermarkets enabled companies like Sainsbury and Tesco to grab more market share from smaller players, and has helped to fuel their rapid growth. Another by-product has been improved margins.
(i) Guinness – The controversial acquisition of Distillers for £2.7bn in 1986 strengthened Guinness’s brand portfolio making it one of the finest in the world. In June 1992, the company was capitalised at over £12bn compared with less than £lbn before the bid, and the shares had appreciated by 300%.
(ii) Tomkins – The successful £192m hostile bid for Pegler-Hattersley in the summer of 1986 transformed Tomkins into a major league predator. In the year to May 1987, Tomkins’ pre-tax profits quadrupled to £30.1m, sales rose from £63m to £270m and earnings per share jumped 70%. By September 1987, the company was capitalised at £360m, and was primed for a succession of further bids on its way to a market capitalisation of £1.4bn and a place in the FT-SE 100 Index.
(iii) Argyll Group – After failing in its bid for Distillers, Argyll focused on food retailing. The acquisition of Safeway for £680m, in February 1987, enabled the company to take a quantum leap into the supermarket top echelon. Argyll’s market capitalisation has increased from £700m before its first bid for Distillers to £3.9bn in June 1992, while sales have more than doubled to £5bn and pre-tax profits have nearly quintupled. The share price is up 75% since the purchase, despite the 1987 crash and a jittery period for the shares in 1988.
There is an added advantage of identifying something new. The story of the stock becomes much more interesting and easy to relate to, resulting in quicker acceptance by the market. The less fundamental support for a share price, the more necessary it is for there to be a good story to give the hope of increased future earnings. If current earnings do not support the share price, hopes of future earnings growth are sometimes all that the share has going for it.
In June 1992, the story of Bernard Taylor and Medeva, for example, could have been passed from broker to private client in this way:
‘Bernard Taylor was Chief Executive of Glaxo. He joined a very small company, Medeva, a couple of years ago. Since then it has made a number of brilliant acquisitions – drug selling organisations in the States, generic drug manufacturers and now it is the biggest supplier of vaccines. It is quite likely to make a big take-over soon. On Medeva’s multiple, anything it buys will enhance assets and earnings per share. The shares could go a lot higher – Medeva is another Glaxo in the making.’
You have to admit that the story is terrific. A large number of people do appear to believe in Medeva, and as a result, in June 1992, the company was capitalised at about £525m on an historic multiple of over 30. Call me old fashioned, but if I was buying into a healthcare business, I would prefer a more established and debt-free company like Amersham International, growing at over 25% per annum on an historic multiple of 20. Medeva has to produce a very substantial increase in earnings to be level with this quality company. Avoid astronomic multiples – companies like Medeva may succeed, but if they falter for a moment there is no safety factor and the share price would collapse.
In telling you about Medeva, I have side-tracked a little from my main point, which I will repeat – the added advantage of something new is that the story of the stock is easy to explain, and the market will quickly grasp it. A good story is a powerful catalyst to help the share price on its upward path. The market likes a good story, and something new adds both piquancy and interest.
The story is also important as a cross-check for you. If you buy a share with passable fundamentals and a good story, you must constantly check that the status quo is unchanged. The story invariably boils down to the reasons for hoping that there will be a substantial increase in future earnings. You must continually refer back to the original story and check each new development against it. Make a quick exit if there are material changes for the worse.
As you read on you will be amazed by the number of criteria for my system which inter-relate with each other. The hip bone is connected to the thigh bone, the thigh bone is connected to the knee bone and so on. Something new is often the cause of relative strength of the shares in the market, of an acceleration in earnings and of an improvement in the estimates of future growth rates and therefore of the PEG factor. Sometimes, when I take a closer look at a share, I discover that something new happened a year or so ago that caused the fundamentals to change. For example, in 1991, I liked Whessoe shares because the prospective multiple was only 7, the earnings growth rate was approximately 15% per annum, the company had a strong liquid position and seemed to be moving from heavy industry to the more attractive instruments business. Whessoe had just purchased an Italian competitor of MTL Instruments. When I examined the position in more detail, I found that a couple of years earlier a new Managing Director and Finance Director had been appointed. Here was the something new that had caused the change in earnings, future growth prospects and the perception of the company as a whole.
As the essential criteria of my system do inter-relate so much, look for one criterion to confirm another. If earnings are accelerating and/or the share price has good relative strength, expect there to be an explanation.
Competitive advantage is a crucially important further criterion which you must fully undertsand.
Imagine that you have identified a dreamlike company, which appears to be growing at 20% per annum, with a P/E ratio of only 10 and a very attractive PEG factor of only 0.5. When you find a share growing at this rate, you know, almost for certain, that at some point in the future, the P/E ratio will be at least 20 and the share would then have a PEG factor of one. However, in a particularly heady phase of the stock market, the multiple could easily rise as high as 25 to 30 times earnings. It is important to understand that the P/E ratio will certainly rise as more and more investors realise that the company churns out earnings increasing at a steady rate of 20% per annum. Going forward five years, earnings would increase from say 10p a share to 25p, and if by then the multiple had risen to 20, the share price would be 500p. This compares with 100p originally, when the dream share was on a multiple of only 10. A gain of 400% – a licence to print money, provided that earnings continued to grow at 20% per annum. You might argue that four or five years could elapse before the multiple rose to 20 or more, but you know that it would simply be a matter of time – not a case of if, but when.
Let us go back to the important proviso, that earnings must grow at 20% per annum. This assumption would have to be based upon as much supporting evidence as possible. I know that you would check the consensus of brokers’ estimates, the outlook for the industry, the past record of the company and the Chairman’s forecast, but there is also another vital criterion that you should apply. You should seek to establish the company’s competitive advantage, which will underpin your earnings growth projections and give them the reliability you are seeking.
Edge is another word for competitive advantage. Something extra, hard to beat and difficult to emulate. If you were living in a small town, which of these businesses would you prefer to own?:
My question is of course heavily loaded. Other people would be unlikely to try to set up in opposition to the local newspaper. Most of the townsfolk would only want to read one local newspaper a week, and there would be insufficient demand in the town to support two of them. The gravel business is again almost impossible to compete with. Planning permission would be required for another gravel pit, and most local councils would not want another eyesore on their doorstep. Also, the cost of transport is such a high proportion of the selling price of gravel that competition from much further away would be out of the question.
The engineering business is very different. The motor manufacturer would have definite views on the prices to be paid for his supplies. The owner of the business would do his best to negotiate but the customer would have the final say, and as the products of the business would not be branded or special in any way, the motor manufacturer could always find another supplier. You can see the contrast with the newspaper proprietor, who could increase advertising prices much more easily. So could the gravel supplier, as long as he kept his prices at a level that still made supply from another area an uneconomic proposition.
The building and decorating business is hardly worth a second thought. There might be no serious competition for years, but the threat would always be there. Very little equipment would be needed for a local handyman who had just retired from other employment to set up as a decorator. He could undercut our building and decorating firm, do a good job, be quickly recommended to other customers and, before you could wink, a friend might join him and they would have an instant decorating business.
In this small town it is easy to see that the first two businesses have a competitive advantage over the others. A clear edge. Now, I want to show you how to identify the competitive advantage of quoted companies on both a national and international scale.
A company has a considerable advantage over competitors through owning one or more great brand names. Coca Cola comes immediately to mind as one of the best-known products in the world. Other examples are Nestlé and Sony. All three companies have supplied quality products over the years and have reinforced their quality image in the public’s mind through persistent and massive advertising. In the UK, Cadbury Schweppes, Guinness and Marks & Spencer are obvious candidates. Their brand names are in themselves tremendous assets that make them very difficult to compete with.
Given the choice, you would rather invest in a business that has a distinct advantage over other businesses than one which is at an obvious disadvantage and open to attack from all and sundry. Not unnaturally, you would prefer the invulnerable to the vulnerable. Businesses like Cadbury Schweppes, Guinness and Marks & Spencer have strong business franchises in the sense that they are comparatively invulnerable and almost impossible to compete with. In contrast, businesses that do not have a franchise of any kind, like small restaurants, dress shops, builders and decorators and general engineering businesses, are very vulnerable. Almost anyone could set up in opposition with a small capital outlay and very little difficulty. Their failure rate is therefore high, as margins frequently come under extreme pressure.
Warren Buffett, the legendary American investor, looks for companies that have good business franchises. Coca Cola, Gillette and Disney would all qualify. In 1991, Buffett invested in Guinness. He sums up this important facet of his philosophy in his own inimitable manner:
‘The test of a franchise is what a smart guy with a lot of money could do to it if he tried. If you gave me a billion dollars, and you gave me first draft pick of fifty business managers throughout the United States, I could cream both the business world and the journalistic world. If you said ‘Go take the Wall Street Journal ’, I would hand you back the billion dollars.
Now, incidentally, if you gave me a similar amount of money and you told me to make a dent in the profitability of or change the market position of the Omaha National Bank or the leading department store in Omaha, I could give them a very hard time. I might not do much for you in the process, but I could cause them a lot of trouble. The real test of a business is how much damage a competitor can do, even if he is stupid about returns.
There are some businesses that have very large moats around them with crocodiles, sharks and piranhas in. Those are the sorts of businesses you want. You want some business that, going back to my day, Johnny Weissmuller in a suit of armour could not make across the moat. There are businesses like that.’
I like Warren Buffett’s homespun style. I can see exactly what he means, although I think he mixes his metaphors a little. The suit of armour might keep out the crocodiles, sharks and piranhas, but even Hollywood’s Tarzan of the Apes would have found chain mail too much of a handicap when swimming a moat.
A similar competitive advantage exists with products that are patented. I have already mentioned Wellcome, which patented Retrovir, their medicant for the treatment of A.I.D.S., and made a fortune by doing so. Patents normally last for sixteen years, but by the time they expire the brand name and acceptance of the product are often so strong that competitors can only make a small dent in profitability. Copyrights last fifty years and can be extraordinarily valuable. The sale of Richard Branson’s Virgin Records to Thorn EMI for £550m illustrates the value of copyright records. Film libraries are also becoming increasingly valuable with the worldwide growth of cable and satellite television, coupled with the inflated cost of making comparable films today. A large number of new broadcasters are now desperately seeking more product.
Government legislation sometimes creates monopolies and oligopolies by granting business franchises. Utilities and cable TV companies are among the best known examples. There is a snag with these kinds of businesses however – they are usually closely regulated so that the customer cannot be abused by unsubstantiated price increases.
Warren Buffett has something to say on this subject too:
‘If I had the only water company in Omaha, I would do fine if I didn’t have a regulator. What you are looking for is an unregulated water company.’
A less precise area is the position some companies achieve by simply being by far the biggest and most dominant in their industry. Potential competitors find the idea of entering the industry too daunting a prospect. Good examples in this country are the Financial Times and Rentokil. You will readily appreciate that the advantage of scale is less attractive to a potential investor than a ‘business franchise’ with very strong brand names, patented or copyright products or protection by government legislation. For leading companies the risk of competition is undoubtedly greater today as business is so international. General Motors and BMC found this to their cost when the Japanese began to concentrate upon the motor industry. IBM too has been feeling the draught since the early seventies.
A different kind of edge over competitors can be obtained by having a niche business with a substantial market share. For example, Druck is a world leader in pressure measuring devices. This kind of business always runs the slight risk that a major company may decide to enter its industry, but for them to do so successfully would probably take more money and effort than would be justified. The risk grows as their markets become bigger and more worthwhile, but meanwhile they usually continue to earn excellent margins and grow far better and more reliably than the average company.
It is instructive to study the performance of different sectors of the stock market over the last twelve years. You will see overleaf how industries which enjoyed the benefit of patents and strong brand names massively outperformed those with no business franchise.
I am not in the least surprised that the Health and Household sector of the market has shown the best return to investors. The businesses in this sector often have patented products with international appeal. High on the list too are brewers, food manufacturers and food retailers, who are protected and helped by their strong brand names. Near the bottom, as expected, you find engineering companies, especially the metal bashers with no branded products or business franchises of any kind. New competitors can easily enter their field. Similarly the dull performance of textile companies is no surprise to me.
These figures may lead you to wonder why any money is ever invested in conventional general engineering companies and in companies with unbranded products in the textile industry. There is, of course, a price for everything but I share your puzzlement. I am also surprised that anyone invests in companies with earnings in decline, companies that have an unattractive P/E ratio, companies that are borrowing far too much and companies that have rapidly declining profit margins. I have long ago stopped worrying about these anomalies though, and thank God there are still some people who do invest in these companies. The important thing to remember is not to join them. You do not have to follow their example. You are looking for companies that have something extra – a competitive advantage. Also, the shares you will be choosing have to satisfy a number of highly selective additional criteria. Not many companies will make the grade.
The brand names of companies like Coca Cola and Guinness are self-evident and very well-known. You know their products and know that the companies in question have a substantial competitive advantage. Your knowledge will be an important factor when you come to the chapter on selecting leading shares and American shares.
Smaller companies are more likely to own lesser-known brand names, patents and copyrights that will eventually become very wellknown if they continue to be successful. They are more likely to be in a dominant or very strong position in a niche business. Recognising these characteristics is very difficult. The first step is to narrow down the field. We know that, with very few exceptions, we are not interested in textiles, heavy plant and machinery, general engineering and electrical businesses, building and contracting, the automotive industry and banks. You will notice that I have used the word ‘general’ when eliminating engineering and electrical businesses, whereas the other industries like textiles have been swept away without qualification. The reason is simple – there are a large number of niche businesses with excellent products in the engineering and electrical section of the market. Common sense will tell you that both MTL and Druck are on to a good thing. There is, however, another useful rule-of-thumb to aid you in your research – if a well managed company is established in a growing niche business, profit margins will be healthily positive and will be tending to increase. Beware if they are declining rapidly. With a company operating on profit margins of only 5% there is little room for error. With the exception of food retailing, for the reasons explained in Chapter Five, 7.5% is a minimum starting base, and 10% to 20% is more in line with our requirements. Companies always state their turnover, so profit margins are easy to calculate. Look at the examples on the previous page.
Some allowance does of course have to be made for general trading conditions. But not much – the best companies will survive recessions better than most and some of the stronger niche businesses will hardly notice them. Glaxo, MTL, Rentokil and Spring Ram have all been excellent investments, massively outperforming companies with no business franchise like Dalgety and Bridon.
Companies with strong business franchises usually enjoy an excellent return on capital employed. Industrial businesses tend to yield far less on capital than ‘people’ businesses such as advertising agencies and insurance brokers, which can show extraordinarily high returns, if goodwill is not factored into the equation. With a small industrial business, I like to see a return of between 20% and 25%. Not so high that it will attract excessive competition but high enough to generate plenty of future growth. The percentage is calculated as follows:
Let us take the example of Kalon in 1991. By examining the group balance sheet you can see that shareholders’ funds (or the net assets) were £28.002m in 1991 and £24.463m in 1990. The other items that must be added to these figures are short-term debts, amounts due under finance leases and hire purchase agreements, long-term debt and provisions. The only short-term debt that needs to be included is ‘Bank overdraft and loans’ shown under the general heading of ‘Creditors due within one year’. In Note 15 ‘Other creditors’, you find the amount due for finance leases and HP agreements. In Notes 16 and 17 you find long-term debts and provisions.
The capital side of the equation is therefore calculated like this:
The average for the year, obtained by simply adding the two totals together and dividing by two, is usually a more accurate measure as capital employed can fluctuate throughout the period. In this case it amounts to £29.186m.
The other half of the equation is the pre-tax profit figure after adding back interest payable and preference dividends. In Kalon’s case this is shown as Operating Profit of £9.177m. To obtain the return on average capital employed, expressed as a percentage, you make the following calculation:
The future growth of a company’s earnings stems to a large extent from the profits, less tax and dividends, ploughed back into the business. The capacity to employ capital at a high rate of return is one of the surest marks of a true growth stock . For example, Rentokil enjoys a five year average rate of return of 53%, and Glaxo is also well above the norm at 37%.
You will notice that I have just mentioned a five year average for Rentokil and Glaxo. This is a far more reliable way of judging the capacity of a business to employ capital exceptionally well. The trend can be important, and the five year average tends to iron out accounting quirks. Now for the good news – if your brokers have access to Datastream, they should be able to obtain all the details for you.
Another interesting way of looking at a share that produces a high rate of return on capital on a regular and reliable basis is to compare it with a gilt. If a gilt produced a return of 20% per annum, of course it would command a premium price of well over par. There is little point in investing in shares which have a low rate of return on capital employed, if you can find companies that have a superior competitive advantage.
A good example of a small company that has an excellent business franchise is Glass’s Guide, now owned by International Thomson Organisation. As the definitive monthly guide for second-hand car dealers, its product is not unduly price-sensitive. It would be difficult for a competitor to set up in opposition. You should be on the alert to identify other businesses of this kind, and intent on avoiding companies with main products which have an obvious risk of substitution. Whoever used to manufacture gas lamps would, I am sure, endorse this caveat. Also beware of companies that are very dependent upon one customer or one supplier, as margins could easily come under extreme pressure. Companies with a product or service that is generally available are always vulnerable to price wars, which can have a devastating effect on margins. For example, in America there was cut-throat competition when the airlines were deregulated, and such well-known companies as TWA and Pan-Am were forced into Chapter Eleven – the brink of bankruptcy.
I find it particularly pleasing that each facet of my system interrelates so well with other facets. Once you have identified a business with a competitive advantage – a strong business franchise – you will usually find that the earnings record is excellent, the growth prospects are good, easy to predict and reliable , and that the share has high relative strength in the stock market. One criterion reinforces another. All of them taken together help to ensure that your final selection is a strong one.
i. Excellent brand names
ii. Patents or copyrights
iii. Government legislation creating franchises (although usually with some regulation)
iv. An established position in a niche market
v. Dominance in an industry
This list is broadly in order of invulnerability to competition.
To find a company with a business franchise is not too difficult, but if you are one of the last people to see the potential the multiple will already be astronomic. We are seeking perfection – a strong business franchise at a reasonable price.
About twenty years ago, I observed that chartists usually had dirty raincoats and large overdrafts. At the time I was thinking of an acquaintance who had fared very badly using technical analysis. Even now I do not know many rich chartists. However, since those early days, I have met one or two who have made their fortune and read about a few more, so I give technical analysis much more credence than before.
In essence, chartists believe that a chart showing the history of a share price reflects the hopes and fears of all investors and is essentially based upon the one indisputable fact – how the share price has actually performed in the market-place. A technical analyst would argue that the market’s perception of a share is a constantly changing illusion. For example, Glaxo’s multiple has fluctuated between 13.4 and 33.8 during the years 1985 to 1992. Glaxo has remained a growth share throughout that period, but the stock market’s perception of the value of a Glaxo share has been continually changing.
Chartists also argue that when share prices move up and down they are likely to trend, and that it is more important to follow the trend than to try to work out the likely earnings per share several years ahead. When an experienced chartist examines a share, he or she will be able to suggest the best point of entry for making a purchase – a point on the chart, where the downside risk is minimised and the upside potential is maximised.
Trends often become self-feeding for reasons that are not difficult to understand. Imagine a share that has risen from 50p to 100p and then falls back to 80p, only to rise again to 100p, fall back again to 80p and then go straight to 120p.
During the consolidation period, when the price ranged from 80p to 100p, many willing sellers would eventually lower their selling limits to achieve a sale. This would of course thin out supply. Similarly, many buyers at under 80p would eventually raise their limits to buy within the trading range, helping to further exhaust the supply and increase the share price. As the price breaks upwards, many investors will let profits run and many fresh buyers will raise their limits to acquire the stock. There is nothing quite like the feeling of greed that comes over you when a share you really fancy seems to be escaping your clutches. You reach for it, pay more and the upward trend becomes self-reinforcing.
I prefer to look upon charts as a tool in the kit, not an end in themselves. Charts provide me with further confirmation that I am proceeding along the right lines, or, alternatively, give me a warning signal, sometimes well in advance of any apparent deterioration in the fundamentals.
When you invest in dynamic growth companies that have strong fundamentals and are due for a status change, the shares should be performing better than the average of the market as a whole. Your broker, almost certainly, subscribes to Datastream and should be able to supply you with charts showing the relative strength of your selections against the FT-A All-Share Index.
Here are four charts showing the relative strength of MTL, Sage, Rentokil and GEC from early 1991 to June 1992.
As you can see, there is no argument about the excellent performance of MTL and Sage, both of which have left the market far behind. Rentokil has also performed well, but has not had the benefit of a major status change in its multiple which has always been on the high side. GEC has been a dull dog, and its relative performance against the market has been poor.
Some brokers provide their institutional clients on a regular basis with details of the relative price action of a large number of shares in major companies. There are also chart services to which you can subscribe, but for practical purposes the Datastream charts give an instant picture of how most shares have been performing relative to the market.
Another rule-of-thumb is to invest in this kind of growth share only when the price is within 15% of its high. This may sound paradoxical as obviously you would prefer to buy a share at a lower price rather than a higher one. However, if a growth share is more than 15% below its high there could be something wrong with the fundamentals – some news that you have not yet heard that is being signalled to you by the poor price action of the shares.
Further evidence of the importance of relative strength is provided by William O’Neil in his book How to Make Money in Stocks . He made a study of the 500 best-performing listed US equities from 1953 to 1990 and found that these stocks averaged an extraordinarily high relative strength rating of 87 during the period before their major price increase began. In other words, on average the 500 stocks out-performed 87% of other stocks in the comparison group during the critical period prior to purchase.
When investing in asset situations, you are not looking for relative strength in the shares. With asset situations you long for the shares to be neglected while you accumulate them, and you might even buy more if they fall a little. You should never average down when buying a growth share.
I am not an expert on charts but I am a friend of Brian Marber, who is one of the leading chartists in the UK, so I decided to ask him for his recommendations on buying and selling signals on individual shares. In Chapter Eighteen, I also question him on the market as a whole.
When Brian Marber was at Simon and Coates, in his circulars on Technical Analysis he included some ‘ Great Lies of the City ’. They are still pertinent today:
‘All the loose stock is now in firm hands.’
‘I know that I can rely on you to keep this to yourself.’
‘Yours is the only research that doesn’t go into the waste paper basket.’
‘I am feeling completely relaxed about the situation.’
‘We are essentially long-term investors and are therefore not interested in short-term market fluctuations.’
Brian is Chairman of Brian Marber and Co., consultants on foreign exchange and stock markets using technical analysis.
Here are the verbatim details of my interview with him:
JS I have explained that Datastream charts and my 15% rule are methods of checking the relative strength of a share. Do you agree with these?
BM Absolutely. I had not heard of the 15% rule, but it certainly makes a lot of sense to me.
JS Are there any other ways that would be easy and practical for the average investor?
BM I like to see shares break out of a base area but, very often, growth shares do not form base areas at all, and they can only be found by using a relative strength chart.
JS How do you read a chart for relative strength? What are the good and bad signs?
BM I read the chart of relative strength just as I would the chart of any other share. I look at patterns, moving averages, trendlines and momentum. A sequence of higher highs and lows is obviously a good sign, whereas a bad sign would be a sequence of lower highs and lows.
JS I always like a growth share that has had a reasonably long period of price consolidation and appears to be about to break out into new high ground. Does this particular pattern have a special name and do you have any pointers to help find this kind of share?
BM As I said, very frequently a growth share won’t have a long period of price consolidation, although its relative strength chart might have a pattern like that.
JS How do you tell if a share with excellent relative strength is about to fall or that there is any likelihood that it will do so?
BM I think it is always difficult to sell a share that has excellent relative strength, but it is of course possible that while the relative strength curve is rising, the chart of the share itself is forming a top area – a head and shoulders, double top or descending triangle. But in each of these cases it would be impossible to sell at the top of the market. Anyway, much as technical analysts like to sell at the top and buy at the bottom, technical analysis being essentially a trend-following discipline, is unlikely to pick absolute highs or lows. Indeed, since I believe that technical analysts are not meant to anticipate the market – the technical analyst is quite likely to be caught at tops and bottoms because he is extrapolating the trend.
JS I understand that when a share price falls below its 90 or 180 day moving average, that is a signal of probable future weakness. Is that so?
BM Not necessarily. Actually, I use 63 and 253 day averages (three trading months and a trading year) and have often found that intermediate reactions frequently end very soon after a share has pulled back to or beneath its 63 day average. You can’t tell whether any particular contact with the 63 or the 90 day average is going to produce a rally and can only discipline yourself like this – if the stock falls below the 63 day average and then rallies above it, the share is only likely to prove vulnerable if it makes a new reaction low. If the share falls beneath its 63 day average and doesn’t rally above it, then a prolonged period of weakness is likely. In case anyone is getting confused over which is the better average to use, it is a matter of personal preference. I like to use a one year average for long-term work because it changes direction less often than an average covering a shorter period. But there are people who use one and a quarter year averages as well. It is really a matter of personal preference. If it works for you – use it.
JS Presumably if a share breaks upwards through its moving average, that can be a buy signal?
BM It is a good signal if a share breaks upwards through its moving average, but if the average itself is declining, the average, or the area on either side of it, may turn out to be a resistance area and block further progress.
JS Does the share price have to break below the moving average for any length of time, or are just one or two days’ confirmation sufficient?
BM A length of time is often better than just one or two days, but sometimes one day is enough, especially with a big fall.
JS How relevant is volume?
BM I was brought up in the London stock market, where volume has only been available on individual shares in the comparatively recent past. I had to do without volume for a great deal of my career, so I am not a volume specialist. I would make the observation though that technical analysts have perhaps been even more successful in forecasting foreign exchange rates than in forecasting equity markets. And in the foreign exchange market, of course (with the exception of the IMM), no volume figures are available. So if technical analysts can survive in the foreign exchange market without volume, it does seem to me that that diminishes its worth in the reading of a share price chart.
One further point, or rather a joke may explain my attitude to volume: a broker rings his client and says, ‘I have good news and bad news.’ The client replies, ‘Tell me the bad news.’ The broker replies, ‘The share that we bought at 50 is trading at 3,’ to which the client replies, ‘What’s the good news?’ Broker: ‘It fell on low volume’.
Shares can fall on low volume, and they can rise on low volume as well. The former is supposed to be good news and the latter, bad, but neither cope with the fact that the share has undoubtedly moved one way or the other.
JS Are moving averages too slow a way of anticipating market movements? Is there a more prescient method?
BM Moving averages are slow – they are a confirming rather than a leading indicator. Momentum, on the other hand, frequently leads the market.
JS Do you mean by ‘momentum’, the rate of change?
BM Yes – the percentage rate of change.
JS Where can investors easily obtain charts that show moving averages?
BM Charts with moving averages are sold by a number of firms, such as Investment Research of Cambridge Ltd.
JS Everyone has heard of a head and shoulders pattern. Is this always a bearish sign?
BM Not at all. A head and shoulders can occur at the top of the market and at the bottom, when it is called a head and shoulders reversal. There is also a head and shoulders consolidation pattern where the market, having moved in one direction, pauses, forms the pattern, and then continues in the same direction.
JS What are the other well-known signals? Is a double bottom meaningful for instance?
BM A double bottom is meaningful and, like the head and shoulders pattern, also permits a precise calculation to be made of where the share is going. As far as other signals are concerned, triangles do frequently appear both as reversal and consolidation patterns.
JS What signs, signals or patterns should investors look for when buying a stake in a dynamic growth share?
BM A steeply rising relative and absolute price curve.
JS Presumably the patterns you would look for in an asset situation or a turnaround or cyclical stock would be very different. Could you elaborate on this?
BM Asset situations and turnaround or cyclical stocks are far more likely to form base areas such as a head and shoulders reversal or a double bottom. I remember during the great bear market of the early 1970s that Albright and Wilson made a very wide double bottom and broke out of the pattern on the bullish side while the market was still going down. Naturally it also showed good relative strength.
JS Is it fair to say that relative strength works best in a bull market and can be dangerous in a bear market?
BM Yes. Everything works better in a bull market and can be dangerous in a bear market – it is always dangerous to ignore the price chart itself. In a bear market a share might show excellent relative strength while falling, albeit falling less than the market itself. In this case relative strength would be positively misleading, whereas a price chart ought to help the investor to avoid the worst pitfalls.
JS Have you any other general tips or advice on charts, especially for dynamic growth shares?
BM A dynamic growth share is clearly going to show a steeply rising curve on its chart, and the longer that trendline has been in existence, the more important it becomes when the trendline is broken. For example, Poseidon, presumed to be a dynamic growth share in early 1970, had held above its original price uptrend for a very long time. As soon as the uptrend broke, the share, having no nearby support because of the lack of long consolidation periods on the way up, had nowhere to go but down, back to where it came from.
JS I remember Poseidon very well.
Brian Marber concluded by telling me a cautionary tale about relative strength. One day a surgeon walked into the terminal ward, situated on the tenth floor of a hospital. The patients were surprised to see him open the window and jump out. On the way down, the surgeon felt well, relatively speaking, compared with the way he felt when he hit the pavement. One of the patients, already confirmed as a terminal case, felt relatively better than the surgeon, when he saw him jump out of the window. A few days later the patient died anyway. The moral is clear – relying on relative strength is all very well provided that you do not die in the process.
We have only skated over the surface with a few thoughts on technical analysis. If you are further interested, an excellent book has been written on the subject – Technical Analysis of Stock Trends , which I refer to in detail under recommended reading in Chapter Sixteen. Meanwhile, I suggest that you use Datastream charts of relative strength and my 15% rule. Also remember that you should watch the relative strength of shares after you have bought them in case they are performing weakly. The price action may be sending you a warning signal about some bad news that is on the way.
The main criteria for selecting small dynamic growth companies have been explained in detail in earlier chapters. Those that remain will be dealt with in this one:
It is a fact of life that elephants don’t gallop and small companies have much greater scope for future growth than very large ones. Wiles Group, capitalised at under £2m, had far more percentage upside potential than Hanson has at over £10bn. Some of today’s very small companies will become the Hansons, Glaxos and Tomkins of tomorrow.
Although I mentioned earlier a limit of £100m market capitalisation, I would be very happy to increase this to £200m or more if all of my other criteria were satisfied. The £100m limit is more a matter of preference than necessity and is far from being carved in stone.
I prefer companies to pay a dividend, as most institutions need an income stream from their investments. Also, the dividend payment and forecast (if any) to some extent corroborate the management’s confidence in the future. The ideal company will have a steadily increasing dividend growing broadly in line with earnings.
When you have found a company that can employ capital at say 20% per annum, you are really much better off if it retains the profits. You should not worry therefore if your dividend is small, provided it is well covered. With the right company, future growth in earnings and capital value will stem from earnings (less dividends paid) being ploughed back into the business and employed at an exceptionally high rate of return.
Any reduction in a company’s dividend is a major event, with serious implications for the share price. By the time the announcement is made much of the damage will have been done. Fortunately, you will usually have some kind of advance warning that the dividend is threatened, and my advice is to sell your shares at the first hint of trouble.
There is a special chapter on value investing which deals with assets in much more detail. When investing in growth shares, assets are of limited importance. Property companies, like Speyhawk and Rosehaugh, that appeared to have substantial asset values, have all but melted away in the recession. In June 1992, Speyhawk has just written off £205m from the property values in its last set of accounts. Conversely, Cadbury Schweppes and Unilever have wonderful international brand names in their balance sheets at a fraction of true worth.
Any company that is growing reliably and well will tend to have an above average P/E ratio that will result in the shares being priced at well above asset value. The more a company earns on capital employed, the higher the growth rate and the higher the P/E ratio and the consequent premium of the share price over the asset value. With a super-growth stock, at a certain point, tangible assets become almost irrelevant. Does it really matter if Rentokil has assets representing only a small fraction of its share price? No-one is bothered about the assets per share, nor are they ever likely to be, provided the company has sufficient working capital, is not being over-geared and has a relatively strong balance sheet. You only need to know that the company of your choice can keep on doing its thing – growing at an above average rate.
I like the Directors to own a number of shares substantial enough to give them the “owner’s eye”, but not so many that they have control, can sit back and could at some future stage block a bid. The important point is for the shareholding to be significant to the director in question. I like to see a good cross-section of the directors with reasonable shareholdings and I always worry if the finance director is not among them.
Directors’ sales are of great interest. The finance director selling 10,000 from his shareholding of 15,000 would be an obvious cause for concern. The founder or major shareholder selling a few shares would not worry me – he has to live. If, however, he sold half of his shareholding, that would unnerve me. I love to see more than one director buying, especially those actively involved in the management of the company which pays their salaries.
There is an excellent publication, Directus , which gives details of directors’ sales and purchases as soon as they become public knowledge. Your broker will almost certainly subscribe to this or to a similar service and should be able to advise you about any significant movements in the shares of companies you have under scrutiny.
Now that you have a better idea of all the criteria for investing in small dynamic growth companies, we will move on to establish the weight that you should attribute to each of them.
I will restate the criteria for selecting small dynamic growth shares before we assess their relative importance:
The first criterion is very important: the five year record provides the back-cloth against which next year’s growth in earnings will help the company to be seen in a more favourable light, which in turn facilitates a status change in the multiple. There is, however, no need to be absolutely dogmatic about the five year record – a shorter period will suffice if there has been a recent sharp acceleration in earnings growth from an easily identifiable source. Some of the best bargains are found when smooth earnings growth has been temporarily interrupted.
Examine the Investors Chronicle review of the 1992 results of Betterware, for example. 1989 seemed to spoil the record but £1.8m pre-tax was made by continuing activities and £1.25m was lost by discontinued activities giving the net result of £550,000 before tax. Betterware’s record has been fantastic ever since, and in June 1992 the shares more than justified their very high multiple. There are many other similar instances. You must not let a minor blip in the earnings record put you off buying a great growth share. It does not matter so much what happened four or five years ago. Of course, you look for a five year record, but be prepared to be very flexible when the near-term record is excellent and the future forecast is very strong. This is where you should put the weight.
The second criterion, a low P/E ratio in relation to the growth rate, with a PEG factor below 0.75 and preferably below 0.66, ensures that the shares are being bought at a very attractive level. This makes a status change very likely. Buying shares with low PEGs also provides the investor with a safety factor . A share growing at 20% per annum on a multiple of 15 with a consequent PEG factor of 0.75 is obviously much safer to buy than a share growing at 15% per annum on a multiple of 30 with a PEG factor of 2.0.
The chairman’s annual statement, and anything he says throughout the year, must be optimistic in tone, as otherwise future growth would be doubtful. If you find that the chairman is usually cautious, you can accept a mildly positive forecast from him. Any negative news or announcements should send you scuttling away to find another share. Strong liquidity, low borrowings and high cash flow are of such importance, particularly in a recessionary climate, that I make the criterion mandatory. I have a degree of tolerance, however, particularly if the growth rate is exceptional and I can see that an uncomfortable liquid position will soon be eased by very high cash flow.
If a share fulfills all of my other criteria except competitive advantage, I usually soon realise that the company must have an advantage that I have failed to identify. A strong business franchise or niche business usually evidences itself by a relatively high rate of return on capital employed. My target figure is 20% per annum, which I am prepared to shade a little on occasions, but in most cases this is mandatory.
It is important to understand that the first five criteria are the essence of the system and are all mandatory. The other criteria provide further protection helping to reduce the risk.
Let us examine the remaining criteria one by one and mark them on a scale of one to ten to give some idea of their relative importance. You will see how they interweave with each other to form a safety net under the already very conservative policy of only buying shares with a low PEG factor, a strong financial position and a competitive advantage:
Very necessary when the earnings record is shorter than usual, as it helps to explain the reason for a sharp acceleration in earnings. Often a wonderful confirmatory bonus providing the reason for further upside in the share price and conversely reducing the downside.
Rating 8
Increased upside potential, resulting in a better risk/reward ratio. You might be surprised, after all I have said to you about elephants not galloping, that a small market capitalisation is classified as important but not mandatory. If all my other criteria were met, I would be delighted to invest in a larger company, but finding a leading company that qualifies is unlikely as the FT-SE 100 Index shares tend to be exhaustively analysed by brokers and institutions. However, in the £100m to £300m bracket you will sometimes find a gem. Rating 7
The high relative strength of shares substantially reduces the risk of there being any nasty surprises. Poor price action can sometimes give you a helpful warning signal to put you on red alert. Rating 6
Always a comfort. On occasions dividend policy can be an early indicator of trouble ahead. Rating 5
A share with a low net asset value would obviously be less prone to a takeover, and in difficult times would have further to fall. Rating 5
To know that the Directors have their personal wealth at stake is a great comfort. Keeping a firm eye on Directors’ dealings also protects your downside.
Rating 5
The ratings are very arbitrary. They are not to be added up like a score but are simply to give you an idea of the relative importance to be attached to each of them.
I will now divide the criteria into three main categories:
Mandatory
1. Five Year Record
2. Low PEG Factor
3. Optimistic Chairman’s Statement
4. Strong Financial Position
5. Competitive Advantage
Important
6. Something New
7. Small Market Capitalisation
8. Relative Strength
Desirable
9. Dividend Yield
10. Reasonable Asset Position
11. Management Shareholding
There can be little compromise on the first five criteria. With the second three, you might put up with one of them being very weak or even unfulfilled, provided all the other criteria were strongly in place. At the time of purchase, relative strength is the least important but subsequently is an excellent way of monitoring any weakness in the share price.
With the last three criteria, substantial compromises can be made as long as most other factors are in place. You always have to bear in mind that selecting a growth share is far more a question of judgement and feel than arithmetic. We will now examine a few real life examples from the past.
First, let us look at a May 1992 placing by stockbrokers, Panmure Gordon, of shares in Industrial Control Services Group plc. The stock market agreed with me that the placing price of 110p was on the low side – the shares opened in late May at 150p giving Panmure’s clients an instant profit of about one-third on their initial investment. Not everyone is a Panmure client, so let us examine the shares at a price of 150p as they were quoted on the first day of dealings and see if they met my criteria:
As you can see there was a major set-back in 1988, but since then earnings have recovered well and in recent years have grown strongly. Not a five year record of growth, but the results for the first half of the year 1991/2 were already known and were very satisfactory. Within a few months the full year’s results will be announced and the five year record will then be in place, though as a base year 1988 should be ignored.
Forecast earnings were 9.1p for the year ending 31st May 1992. The difference between 9.1p and 7.3p is 1.8p giving a growth rate for that year of 25%.
Now we come to a small complication – the earnings per share of 9.1p have to be adjusted downwards to allow for the impact of 50% of a subsidiary, ICS Bailey, being sold. It is made clear in the prospectus, that ICS Bailey’s contribution to the £4.5m profit forecast was £1.19m before tax. Half of this will be lost after the sale, reducing the after tax forecast from £2.94m to £2.54m, giving revised earnings per share on the adjusted average weighted capital of 7.7p. However, no allowance was made for any income from the cash to be received for their 50% of ICS Bailey, and profit forecasts for prospectuses so near to the end of the financial year are usually conservative, so I feel very comfortable with 8p EPS for the purpose of calculating the P/E ratio.
As the last month of Industrial Control Systems’ financial year is May, it is reasonable to work on a 1992/3 prospective price earnings ratio. In the growing market for safety systems, you could reasonably anticipate that growth would continue at the same rate of 25% per annum for the next few years. This would lift earnings of 8p to 10p giving a prospective 1992/3 multiple of 15 at a price of 150p. The prospective PEG is therefore 25 (the growth rate) divided into 15 (the prospective multiple) – an attractive 0.60.
You already know from the placing particulars that the profits for the half year ended 30th November 1991 were well on course. Under the heading of ‘Prospects’, you learn that ‘The Directors believe that the potential for further growth is excellent.’ You also note that the safety systems market, which is in excess of $750m, is growing at about 10% per annum and in the UK a number of new electricity generation projects have been announced which should benefit the group. Coupled with the recent record, this is enough.
After the placing, net tangible assets will exceed £16.6m. The total of bank overdrafts, commitments under hire purchase and finance leases and mortages less cash in hand will be just over £6.9m making net debt about 40%. The quick ratio will be 1.15:1.00. Neither are very attractive but they are passable.
The ICS Group is a technical leader in the growing safety industry. Major installations have been completed for such important customers as British Gas, BP, Exxon, Shell, Chevron and Total. Operating profits were running at just over 10% of turnover in 1991 and the return on capital employed in that year was over 25%.
The Offshore Safety Act 1992 gave new regulatory power to the Health and Safety Executive and increased penalties for breaches of off-shore safety regulations.
At 150p the market capitalisation was just under £60m. Well within our limit.
If the opening price in comparison to the placing price was anything to go by, the future relative strength of the shares should be excellent.
The yield at 150p is an acceptable 3.2%.
The net assets of just under one-third of market capitalisation are not attractive in their own right but provide a small degree of comfort.
Directors will own over 60% of the shares after the placing. Not ideal, but acceptable.
ICS shares are a buy, as they fulfill most of the criteria of my system and, in particular, the prospective PEG is a very attractive 0.60. With the safety business in mind, let us return to MTL Instruments and see how that company measures up to my criteria, after a massive price increase from 150p in March 1991 to 295p a year later and onwards to 340p in May 1992.
The record of earnings was over 20% compound during the previous five years. 1991 earnings were 16.6p per share. In May 1992 the consensus forecast of two brokers was for 1992 earnings of 18.3p – a gain of just over 10%. Taking the consensus figure, the prospective multiple at 340p is 18.6 times earnings. The PEG on a 10% growth rate would therefore be a very high 1.86, making the shares a clear sell.
However, I believe that MTL is a fine company, which with its splendid record should be given the benefit of the doubt. My own belief is that, as in the past, the brokers’ forecasts will prove to be conservative, and a more likely earnings per share figure for 1992 will be 19p per share, giving a prospective multiple of 17.5 and a growth rate of 14.5%. This would bring the PEG down from 1.86 to 1.20. As you know, I believe that superb growth shares like MTL should remain a long-term hold through thick and thin, but a prospective PEG of 1.20 based on an optimistic assumption is a test of character that I would probably fail. Certainly at 340p, the shares cannot be a buy in comparison with other growth companies, which are ripe for the same kind of status change that MTL has already enjoyed. On the other hand, MTL is a classic growth company which I would always keep under review, waiting for a better moment to repurchase.
Let us look at another share, Victaulic, which makes those yellow pipes you have often noticed stacked by the side of the road waiting to be laid. The gas and water industries are its main customers. The record of earnings growth has been excellent in recent years as evidenced by the article in the Investors Chronicle dated 6th March 1992.
The industry is relatively recession-proof and cash balances are strong but the forecast of future profits is only £l5.5m, meaning that the growth rate is slackening. More recently, in April 1992, The Estimate Directory shows a consensus of ten brokers forecasts of £15.9m. Taking this figure, there would be an increase of £1.6m over the previous year’s total of £14.3m, showing growth of 11%. After allowing for tax on the £15.9m, the prospective multiple would be approximately 16. The prospective PEG would then be calculated by dividing 11 (the growth rate) into 16 (the prospective multiple), resulting in a lofty PEG of 1.45. Far too high – an excellent share maybe, but with an insufficient safety margin for our system.
Now, I suggest we re-visit Sage to see if after such astonishing growth that company measures up to our criteria today. You will remember that Sage’s shares were a buy at 203p and by May 1992 they had risen to 469p. At this much higher level are they a buy, a hold or a sell? For a change, this time I will show an extract from the May 1992 Estimate Directory , which gives most of the information needed to make a judgement.
As you can see, the phenomenal growth rate of the recent past seems to be slowing down. The brokers’ consensus forecast for the year ending September 1992 is earnings per share of 29.5p making the growth rate for that year 16%. However, the half-yearly results announced in April led me to a different conclusion. In 1991, the first half showed EPS of 11.6p followed by 13.9p in the second half, to give a total of 25.5p for 1991. The first half of 1992 showed EPS up 25% at 14.5p with a recent US acquisition, DacEasy, making its first full six months’ contribution. I suspect that earnings for the second half will be up by at least 20%, giving 17.4p for the second half, and a total of 31.9p for 1992. As you will see, my estimate of 31.9p is above all of the brokers’ estimates, so I will take the top forecast of 30.9p as my base for calculating that at 469p the shares are on a prospective 1991/2 P/E ratio of just over 15.
The future consensus forecast estimates indicate that 1993 EPS will be 33.5p with growth of 13% (excellent in a recession, but not for Sage). The brokers’ forecasts made after the interim results were announced in April show a higher estimated average EPS for 1993 of 34.3p. However, I believe that as in the previous year the top forecast of 36.2p made by UBS Phillips & Drew will be more likely to prove correct. You will find that it usually pays to give the benefit of the doubt to great growth stocks, especially those, like Sage, that enjoy a rate of return on capital employed of well over 100%.
What does all this add up to? On the top forecast of EPS for 1992 we have a figure of 30.9p and for 1993 36.2p. The estimated growth in EPS of 5.3p is 17%. The prospective P/E ratio for 1991/2 is 15. The prospective PEG for 1991/2 is therefore 17 divided into 15, which is about 0.9. Not a system buy, but definitely a hold, especially bearing in mind the expenses of switching. Also, there is the benefit of the interest-free loan from the government of about 100p per share, enjoyed by shareholders who purchased their shares at 203p and have not yet sold them, and as a result have not had to pay capital gains tax on their profit.
Sage’s financial year ends on 30th September. If the share price stays the same the market will begin to look at Sage on a prospective multiple for 1992/3 of about 13. With the growth rate for the year estimated at 17%, that would make the 1992/3 PEG a more attractive 0.75 – just a buy within our system. As I have illustrated in Chapter Three with the example of MTL Instruments, if you time your purchase well, a rapidly growing share can often be bought very cheaply just before the market’s perception of the share moves from the historic to the prospective multiple. The only snag with this approach is that you lose more time than usual while you wait for the shares to appreciate in value, and you take two years’ profits on trust instead of only one. If you wait for the results for the previous year to be announced, you only take a risk on the forecast profit. However, if you missed the boat previously with a share like Sage and you are prepared to take the risk on two forecasts, this approach can sometimes offer you an opportunity to climb aboard.
Let us look at The Body Shop, a great growth company that is frequently in the news and has been a very rewarding investment for the brave. If you had bought shares in the market immediately after the company obtained a quotation in 1984, you would have paid a premium of 50% over the offer for sale price. As the shares were floated on a prospective multiple of 24, that would have meant paying 36 times prospective earnings. There have been several scrip issues and rights issues since then, but you would have made over sixty times your money. The shares have always commanded a high P/E ratio and have always seemed expensive in relation to the market as a whole. However, in PEG terms the shares have often been relatively cheap. After all, with a growth rate forecast at times to be as high as 50% per annum a prospective P/E ratio of 36 means that the PEG would be 0.72 and would fall just within our system. The difficulty of course is believing that a growth rate of 50% per annum can be maintained for any length of time. The past is easy. Let us look at The Body Shop in July 1992.
The Estimate Directory shows the price at 278p, the consensus forecast of growth for next year at 29%, and on that assumption, a prospective P/E ratio of 24.6. The prospective PEG is calculated by dividing 29 into 24.6 giving 0.85, which is relatively attractive for a leading supergrowth share.
The key point with The Body Shop is that the company’s exceptional growth rate commands a high multiple. If you had bought the shares, you would have had a few uneasy moments when the directors sold some of theirs and when there were bouts of unfavourable publicity. However, by and large you would not have seen the PEG move much above 1.2 until 1990, when growth flattened out temporarily.
The worry about buying a share like The Body Shop is that if growth suddenly stops the shares have a long way to fall, and there would be a rush for the exit. On the other hand, you cannot expect to multiply your money sixty times in a few years without taking some risk.
It is interesting to note that The Body Shop was a new issue of the last decade. Sage was a much more recent one. Both are exceptional growth shares starting as yearlings, one of which you hope will have the strength of character, ability and persistence to become another Red Rum.
There are still plenty of opportunities around in the new issue market. I have already mentioned ICS. Another recent issue was British Data Management which was placed by Rothschild in late March 1992 around the time of the General Election. The company appears to have the makings of an exceptional growth stock, so I suggest we analyse the statistics together in some detail. It is worth studying my approach, because, to justify buying the shares, you need to be a little inventive when dealing with the future growth rate and the PEG.
BDM is in the business of storage management and the distribution of commercial and oil exploration data. The group has 40% of the market for the fast growing oil and gas exploration industry, with important customers of the calibre of BP. Charges are made for annual storage and for the retrieval of documents when required. The service is very sophisticated and, needless to say, computer-based.
The issue was a flop because of uncertainty before the General Election, and the shares languished for some time under the issue price of 125p. Let us be conservative though and look at the numbers based on the issue price.
As you can see by studying the placing document, the year end is June, and on the Directors’ forecast of £2.38m EPS are 10.9p.
They do however rise to 11.4p if, as you should, you adjust to assume that the issue had taken place at the beginning of the financial year. Let us now look at the recent record of profits and EPS growth:
We would need a 1993 forecast to ascertain whether or not the shares fulfilled our most important criteria of a high future growth rate and a relatively low P/E ratio. We cannot let this company get away, so we have to improvise and make a few guesses. 1991 profits were more than double those of 1990, and 1992 profits were more than 50% up on 1991. The difference between the first half of 1991/2 of £1.46m and the forecast for the whole financial year of £3.5m is over £2m. Doubling that figure we arrive at £4m, and allowing for the next half year’s growth we could safely add another £500,000 to give an estimate for 1992/3 of £4.5m.
In a similar way, I would calculate that 1993/4 profits would be about £5.5m. I know that I have not allowed for possible seasonal factors in the half year’s results and that my approach is very rough and ready, but I am comforted by my liking for the business which seems to me to have excellent potential for further growth.
Now let us look again at the profits forecast of £3.5m for 1991/2 and the 11.4p of EPS shown in the placing document. As you can see from the profits record, there were substantial losses in the early years, giving rise to tax losses that were available to carry forward against future profits. The result is that the tax charge of £850,000 on the pro-forma forecast is abnormally low and the tax charge on the 1991 results was almost non-existent. The estimated tax charge for 1991/2 increased by £360,000 – simply by adding the national interest saving of £1,120,000 to profits. A normal tax charge is about one third, which in this case would have meant an extra £373,000 – very close to £360,000, clearly indicating that the tax losses have been used up and the company will in future be paying a normal tax charge.
If we assume a normal tax charge of one-third for 1991/2 on the pro-forma profits of £3.5m, we will arrive at a net figure of approximately £2,335,000. There are going to be 23,262,398 shares in issue after the placing, so earnings per share amount to almost exactly l0p (it beats me why placing documents do not make this kind of thing absolutely clear). For 1992/3, our £4.5m estimate with a normal one third tax charge would give a net EPS figure of about 13p and for 1993/4 the £5.5m would give about 16p.
We now go back to the drawing board to calculate the PEG. As we are so near the end of the financial year and the company is fast-growing, I am going to use the prospective PEG for 1992/3. The estimated EPS are 13p a share, the issue price is 125p, so the prospective P/E ratio is about 10. The following year’s growth is about 22%; the prospective PEG can therefore be calculated by dividing 22 into 10 to arrive at a very attractive 0.45.
The rest of the criteria are fine: there will be no debt after the placing, the company is well established in its industry, the rate of return on capital employed is a very satisfactory 22.5%, the new round of North Sea licencing was announced in March 1992, the market capitalisation at £29.1m is small and the dividend yield is 4.25%. Allowing for properties not being worth book value, net assets are about one-third of the share price, and management has a substantial residual shareholding. The only criterion that is not satisfied is relative strength, which was poor. It is, however, easy to understand that the General Election would have affected sentiment, so I take this shortcoming with a pinch of salt.
I have dwelt at great length on BDM because, as you can see, I had to do some homework to find out if the shares were really a buy. There was the lesson of the abnormal tax charge, but more importantly the way to ‘construct’ the profit forecast and estimate the rate of future growth. Time will tell if my estimates are right. Barring accidents, I feel reasonably certain that they will prove to be conservative.
The most important single point to grasp is that it is difficult to find a share with a very low P/E ratio in relation to the growth rate. You will find a few each year by browsing through the Investors Chronicle , through recommendations from your broker and investment newsletters and by general reading. You will also find some excellent investments among new issues, which are often offered at a discount to normal market prices. However, as with BDM, you will sometimes have to work on the share a little before you can decide whether or not it is a system selection. This is especially the case with new issues, which frequently come to the market near to the end of their financial years. You may have to go forward a few months to anticipate how the shares will look then. You may have to do some work on the figures and take slightly more risk than you would normally like to bear, so that you can beat other investors to the punch. You will probably be selling by the time that they have fully realised the attractions of the share.
You will have noticed that I have been fairly dismissive about most of the criteria other than the mandatory ones. Once the attractive PEG is in place, the Chairman’s forecast (or constructed forecast) is optimistic, and the company has a strong financial position and a high rate of return on capital employed, I begin to feel enthusiastic about the shares and take some persuading that I could be wrong. Strangely enough, most of the other criteria do usually drop into place. This is hardly surprising – if a company has a competitive advantage and something new has been happening, you would expect earnings growth to be exceptional.
Poor relative strength on its own should not put you off, but any weakness in the share price should alert you to the possibility that something could be going wrong. With an established growth stock, an indifferent net asset value is not a cause for concern. You should only begin to worry when a number of the non-mandatory criteria are not in place. Taken together they form a safety net, which will only break if several of the strands are frayed or missing.